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ABSTRACT OF THE DISSERTATION 
ASSESSMENT OF THE OCCURRENCE AND POTENTIAL RISKS OF 
PHARMACEUTICALS AND THEIR METABOLITES IN FISH AND WATER 
USING LIQUID CHROMATOGRAPHY MASS SPECTROMETRY 
by 
Jian Wang 
Florida International University, 2013 
Miami, Florida 
Professor Piero Gardinali, Major Professor 
A comprehensive method for the analysis of 11 target pharmaceuticals 
representing multiple therapeutic classes was developed for biological tissues 
(fish) and water. Water samples were extracted using solid phase extraction 
(SPE), while fish tissue homogenates were extracted using accelerated solvent 
extraction (ASE) followed by mixed-mode cation exchange SPE cleanup and 
analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS). 
Among the 11 target pharmaceuticals analyzed, trimethoprim, caffeine, 
sulfamethoxazole, diphenhydramine, diltiazem, carbamazepine, erythromycin 
and fluoxetine were consistently detected in reclaimed water. On the other hand, 
caffeine, diphenhydramine and carbamazepine were consistently detected in fish 
and surface water samples.  
In order to understand the uptake and depuration of pharmaceuticals as well as 
bioconcentration factors (BCFs) under the worst-case conditions, mosquito fish 
were exposed to reclaimed water under static-renewal for 7 days, followed by a 
vi 
14-day depuration phase in clean water. Characterization of the exposure media 
revealed the presence of 26 pharmaceuticals while 5 pharmaceuticals including 
caffeine, diphenhydramine, diltiazem, carbamazepine, and ibuprofen were 
present in the organisms as early as 5 h from the start of the exposure.  
Liquid chromatography ultra-high resolution Orbitrap mass spectrometry was 
explored as a tool to identify and quantify phase II pharmaceutical metabolites in 
reclaimed water. The resulting data confirmed the presence of acetyl-
sulfamethoxazole and sulfamethoxazole glucuronide in reclaimed water. To my 
knowledge, this is the first known report of sulfamethoxazole glucuronide 
surviving intact through wastewater treatment plants and occurring in 
environmental water samples. 
Finally, five bioaccumulative pharmaceuticals including caffeine, carbamazepine, 
diltiazem, diphenhydramine and ibuprofen detected in reclaimed water were 
investigated regarding the acute and chronic risks to aquatic organisms. The 
results indicated a low potential risk of carbamazepine even under the worst case 
exposure scenario. Given the dilution factors that affect environmental releases, 
the risk of exposure to carbamazepine will be even more reduced.  
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CHAPTER 1 
Introduction  
 2 
1.1 Occurrence of pharmaceutically active compounds in the environment 
Pharmaceutically active compounds are now well-acknowledged environmental 
pollutants. They are released into the environment largely through the discharge 
of wastewater treatment plants (WWTPs) as a result of excretion and metabolism 
by humans and animals, and additionally, disposal of unused or expired drugs 
(Daughton and Ternes 1999; Miao and Metcalfe 2003; Vanderford et al. 2003). 
However, most WWTPs are not specifically designed to remove most of the 
pharmaceuticals, thus these compounds are present in reclaimed and surface 
waters in a wide range of concentrations (Heberer 2002; Boyd et al. 2003).  
Besides parent pharmaceuticals, the presence of pharmaceutically active 
compounds in the environment can also be in the form of transformation products 
(i.e. 10,11-dihydro-10,11-dihydroxycarbamazepine, the major metabolite of 
carbamazepine, and norfluoxetine, the major metabolite of fluoxetine) (Miao and 
Metcalfe 2003; Brooks et al. 2005; Miao et al. 2005; Chu and Metcalfe 2007). 
Parent drugs can be excreted as the unchanged form (Miao et al. 2005) whereas 
transformation products can be formed as metabolites by undergoing chemical or 
biochemical transformation (Gobel et al. 2004) or as photodegradation products 
by exposure to sunlight (Bonvin et al. 2012). Current research is heavily focusing 
on unchanged parent drugs (Celiz et al. 2009). However, it is important to realize 
that the exposure to metabolites may have hazardous effects similar to those of 
the parent drugs (Bedner and MacCrehan 2006).  
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1.2 Adverse effects under chronic exposure 
Although concentrations in environmental water bodies are typically at ng/L to 
low µg/L level, these organic pollutants may still pose risks to aquatic species 
under chronic long-term exposure (Vanderford et al. 2003; Brooks et al. 2005; 
Owen et al. 2007; Gunnarsson et al. 2008). For instance, after a 21-day 
exposure, fluoxetine was shown to induce vitellogenin in male fathead minnows 
(Pimephales promelas) at 28 ng/L and venlafaxine caused mortality of fathead 
minnows at concentration as low as 305 ng/L (Schultz et al. 2011). Similarly, 
plasma samples from the rainbow trout (Oncorhynchus mykiss) exposed to 
sewage effluents were analyzed for 25 pharmaceuticals, of which levonorgestrel 
was detected in fish plasma at concentrations (8.5-12 ng/mL) exceeding the 
human therapeutic plasma level (Fick et al. 2010). Because many aquatic 
species were shown to have similar physiological receptors to those the 
pharmaceuticals are originally intended to react with in humans (Gunnarsson et 
al. 2008; Quinn et al. 2009), the data suggested a high risk of pharmacological 
effects on rainbow trout (Fick et al. 2010).  
Another study concerning the uptake and depuration as well as bioconcentration 
factors (BCFs) of pharmaceuticals including moclobemide, 5-fluoruracil, 
carbamazepine, diazepam, carvedilol and fluoxetine was conducted in freshwater 
shrimp (Gammarus pulex) and water boatman (Notonecta glauca) after a 2-day 
uptake phase (Meredith-Williams et al. 2012). The results showed that BCFs in 
freshwater shrimp were significantly higher than those found in water boatman, 
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implying that pharmaceuticals may possess even higher risks to smaller aquatic 
species as environmental pollutants.   
1.3 Reclaimed water exposure 
A freshwater pond located at Florida International University Biscayne Bay 
Campus (North Miami Beach, FL) continuously receives storm water runoff and 
reclaimed water from a local WWTP through daily sprinkler irrigation. The source 
of reclaimed water was Miami-Dade Water and Sewer Department North District 
Wastewater Treatment Plant. Pure oxygen activated-sludge was used in the 
WWTP as the main secondary treatment process. Extra filtration and disinfection 
were applied to effluents before release to make the reclaimed water ready for 
use in irrigation. Fish are sensitive indicators for the substances that enter 
aquatic ecosystems (EPA 2009). Therefore, the aquatic organisms living in this 
pond are likely to be chronically exposed to the contaminants from reclaimed 
water. It is also expected that aquatic systems like this freshwater pond 
influenced by substantial inputs of reclaimed water may represent a good model 
to study the exposure of biological resources to mixtures of pharmaceuticals 
under relatively natural conditions (Brooks et al. 2006).  
1.4 Current analytical protocols of detecting pharmaceuticals in water and 
biological samples 
On the basis of the complexity of environment matrices and the multiple 
functionalities of emerging contaminants as target compounds, recently 
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described analytical protocols for the determination of pharmaceuticals in both 
wastewaters (Segura 2007; Lajeunesse et al. 2008; Segura 2009) and biological 
organisms (Tavazzi et al. 2002; Brooks et al. 2005; Chu and Metcalfe 2007; 
Berrada et al. 2008) have focused on rather specific classes of compounds. 
Antidepressants (Brooks et al. 2005; Chu and Metcalfe 2007; Lajeunesse et al. 
2008) and antibiotics (Segura 2007; Berrada et al. 2008; Segura 2009) are the 
two classes that have been studied the most. As the list of compounds found in 
field collected fish samples expands, the need to develop simultaneous 
screening methods for multiple classes of drug residues increases as well 
(Balmer et al. 2004; Duedahl-Olesen et al. 2005; Buser et al. 2006; Rudel et al. 
2006; Mottaleb et al. 2009). At present, the general approach employed for the 
analysis of multi-class pharmaceuticals in fish involves extraction of 
homogenized tissue with 1:1 mixture of 0.1 M acetic acid and methanol (Ramirez 
et al. 2007), or acetonitrile combined with limited cleanup to back-extract lipid 
material followed by liquid chromatography-mass spectrometry (LC-MS) analysis 
(Smith et al. 2009). Additionally, the use of solid-phase microextraction (SPME) 
techniques has also been explored as surrogates to estimate the potential 
occurrence and uptake of pharmaceuticals in living fish by assuming similar 
partition behavior between the SPME devices and the fish tissues placed in 
contaminated environments (Zhou et al. 2008). 
Accelerated solvent extraction (ASE) involving high pressure and temperature 
has been shown to efficiently extract a wide range of compounds from fish 
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tissues (Draisci et al. 1998; Datta et al. 2002; Tavazzi et al. 2002; Wahlen 2004; 
Chu and Metcalfe 2007; Haglund et al. 2007; Berrada et al. 2008; Llorca et al. 
2009; Losada et al. 2009; Lund et al. 2009). Meanwhile, HLB polymeric 
cartridges are routinely used as SPE sorbent for cleanup of complex 
environmental samples prior to LC-MS analysis. However, on the basis of 
considerable variation in lipophilicity and pKa among different classes of 
pharmaceuticals, optimum cleanup efficiency can be compromised by differential 
retention behavior of target analytes on the sorbent. In contrast, mixed-mode 
cation exchange (MCX) cartridges can accommodate both neutrals and cations 
providing better selectivity during elution steps. For instance, Chu et al. (Chu and 
Metcalfe 2007) developed a method to determine paroxetine, fluoxetine and its 
metabolite in fish tissue using accelerated solvent extraction followed by MCX 
cleanup offering better recoveries and minimized matrix interferences. Because 
of the capabilities mentioned above, mixed-mode MCX cartridges will likely 
provide the needed retention for the multiple classes of pharmaceuticals 
proposed herein. 
1.5 Why is it needed to improve the throughput of current on-line SPE 
methods for pharmaceutical analysis? 
As the list of pharmaceutically active compounds being reported in various 
environmental matrices keeps growing, it is of obvious importance to develop 
new analytical techniques that are more effective at analyzing multiple 
components in a large number of samples in limited time (Balmer et al. 2004; 
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Buser et al. 2006; Mottaleb et al. 2009). In order to address the needs for lower 
detection limits and higher sample throughput, an on-line SPE coupled to mass 
spectrometry detection was developed to eliminate several preparation steps 
such as evaporation and reconstitution (Segura 2007; Garcia et al. 2009; Wang 
and Gardinali 2012). More recently, on-line SPE LC-MS/MS has become a more 
desired technique in routine analysis of aqueous samples, especially for the 
samples that are time sensitive and need large injection volume to improve 
sensitivity.  
The time for a typical on-line SPE LC-MS/MS analysis consists of autosampler 
preparation time, sample withdraw time, SPE loading and elution time, and 
separation time. On the basis of the fact that loading speed is at 1 mL/min, total 
run times could be quite long when large sample volume (i.e. 20-50 mL) is used 
to improve detection limits. To shorten the time between injections, “look ahead” 
mode can be enabled so that the autosampler sets up for the next injection 
during the current run. Although the “look ahead” mode can be used to 
incorporate autosampler preparation and sample withdraw time into 
chromatography time, the sample is still aspired into the sample loop during the 
next run cycle. In addition, the dead volume of large sample loops (>5 ml) 
creates a massive delay of gradient changes and increases the uncertainty of 
mobile phase mixing.  
In the present study, default autosampler program commands were modified 
from 1-draw sample, 2-move to injection port, 3-aspire sample, 4-inject and 5-
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washing to 1-inject, 2-wait, 3-switch injection valve to load, 4-washing, 5-draw 
sample, 6-move to injection port, and 7-aspire sample. The amount of time that 
the modified autosampler program took was compared with those needed for the 
default injection mode and “look ahead” mode. Efficiencies for the washing steps 
of injection syringe and sample loop which lead to carryover were also 
investigated among the default autosampler program, look ahead, and the 
modified autosampler program for all the compounds in laboratory routine 
analysis of water samples. 
1.6 Why is pharmacokinetics under the “worst case scenario” important?  
First of all, pharmacokinetic data describing the uptake and depuration of 
pharmaceuticals by aquatic species are extremely limited compared to those in 
mammals (Paterson and Metcalfe 2008; Meredith-Williams et al. 2012), thus it is 
important to study the uptake and depuration rates in systems that may represent 
“worst case exposure” without compromising the environmental relevance (Fick 
et al. 2010). Most aquatic monitoring studies designed to simulate exposure 
under environmentally relevant concentrations were performed in artificially clean 
matrices (Nakamura et al. 2008; Paterson and Metcalfe 2008; Hoang et al. 2011; 
Meredith-Williams et al. 2012), often with exposure concentrations still higher 
than those would be found under natural conditions by one or more orders of 
magnitude (Paterson and Metcalfe 2008; Hoang et al. 2011). Although this 
approach maximizes the chances of quantifying any compounds that might 
accumulate with confidence, results are often not in good agreement with those 
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from the field (Nakamura et al. 2008; Paterson and Metcalfe 2008; Meredith-
Williams et al. 2012). Reclaimed water produced by conventional primary and 
secondary treatment offers good surrogacy for a worst case exposure scenario 
and could be used to predict the extent of bioconcentration and toxicological 
thresholds in aquatic organisms without resourcing to unrealistic concentrations 
(Paterson and Metcalfe 2008). 
1.7 Identification of pharmaceutical metabolites in reclaimed water 
Numerous analytical instruments have been applied to investigate the 
occurrence of parent drugs in a variety of environmental matrices (Vanderford et 
al. 2003; Davis et al. 2006; Kwon and Armbrust 2006; Ramirez et al. 2007; 
Schultz et al. 2010; Wang and Gardinali 2012). In contrast, little attention has 
been paid to the identification, let alone quantification, of pharmaceutical 
metabolites (Celiz et al. 2009) because there could be numerous metabolites 
from one parent drug and it is also practically impossible to purchase or 
synthesize standards for all the metabolites, not to mention the economical 
unsoundness. As a result, current targeted analysis of metabolites using tandem 
mass spectrometry is only limited to pharmaceuticals whose metabolites are well 
studied from clinical data and standards for the metabolites are readily available 
to purchase (Miao and Metcalfe 2003; Gobel et al. 2004; Miao et al. 2005). 
However, the increasing number of studies reporting the presence of metabolites 
in the environment underlined the urge to include metabolites as an important 
part of routine analysis of pharmaceuticals. For instance, several LC-MS 
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methods have been developed to determine carbamazepine, one of the most 
frequently detected pharmaceuticals in WWTP effluents and surface water, along 
with its major phase I metabolites in aqueous samples (Miao and Metcalfe 2003; 
Miao et al. 2005). Interestingly, metabolite 10,11-dihydro-10,11-
dihydroxycarbamazepine was found to be the dominant analyte which had a 
concentration 3 to 4 times higher than that of carbamazepine in wastewater 
(Miao and Metcalfe 2003). A significant increase of the parent drug was also 
observed in the treated wastewater relative to concentrations in the untreated 
wastewater, suggesting that some phase II metabolites could have been 
transformed to free form by cleavage of the conjugates during the treatment. The 
increase of the parent drug is likely related to the fact that hydroxylated 
metabolites of carbamazepine occur primarily in conjugated forms such as 
glucuronidation in body fluids (Miao et al. 2005).  Therefore, it is increasingly 
important to include phase II metabolites when assessing the occurrence, fate 
and transport of pharmaceuticals in the environment. 
1.8 Driving Hypothesis 
The primary driver is the concern that long-term exposure to low levels of 
pharmaceutical residues could have adverse effects on aquatic organisms.  
1.9 Objectives 
The main objectives of the present study are to develop sensitive and robust 
analytical methods using mass spectrometry to investigate the occurrence of 
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pharmaceuticals and metabolites in the environment, and to understand the 
uptake and depuration of pharmaceuticals in biological tissues. The ultimate goal 
is to assess the ecological risks associated with the exposure.   
In chapter 2, an LC-MS/MS method for the analysis of 11 target pharmaceuticals 
in biological tissues (fish), reclaimed water and surface water is described. BAFs 
for the detected pharmaceuticals in mosquito fish sampled from a freshwater 
pond directed affected by reclaimed water were calculated using the developed 
method. 
Chapter 3 describes the modification based on existing on-line SPE LC-MS/MS 
to improve the throughput and to reduce carryover. 
Chapter 4 explains the uptake and depuration as well as bioconcentration factors 
of pharmaceuticals in reclaimed water by mosquito fish under worst-case 
exposure scenario.  
Chapter 5 describes the exploration of using liquid chromatography ultra-high 
resolution Orbitrap mass spectrometry to identify and quantify phase II 
pharmaceutical metabolites in reclaimed water. 
In Chapter 6, the potential risks of five bioaccumulative pharmaceuticals 
including caffeine, carbamazepine, diltiazem, diphenhydramine and ibuprofen 
detected in reclaimed water were assessed using probabilistic approaches.  
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CHAPTER 2 
Analysis of selected pharmaceuticals in fish and the fresh water bodies 
directly affected by reclaimed water using liquid chromatography-tandem 
mass spectrometry 
(Jian Wang, Piero Gardinali, Analytical and Bioanalytical Chemistry (2012) 
404:2711–2720) 
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2.1 Introduction 
Because of increasing reports of their occurrence in water, wastewater, soil, 
sediment and biosolids (Daughton and Ternes 1999; Heberer 2002; Boyd et al. 
2003; Ramirez et al. 2007; Ramirez et al. 2009), pharmaceuticals including drugs 
and their active metabolites have been recognized as emerging environmental 
contaminants. Municipal wastewater has been identified as one of the main 
routes bringing these pharmaceuticals into the environment (Daughton and 
Ternes 1999). This is likely because wastewater treatment plants (WWTPs) are 
not specifically designed to remove most of the pharmaceuticals, thus these 
compounds are continuously released into reclaimed and surface waters in a 
wide range of concentrations (Heberer 2002; Boyd et al. 2003). Fish are sensitive 
indicators for substances that enter aquatic ecosystems (EPA 2009). Numerous 
studies have shown that long-term exposure to pharmaceuticals and personal 
care products (PPCPs) may result in accumulation of parent compounds, their 
metabolites, or both in tissues of aquatic organisms, suggesting that further 
studies on secondary effects of PPCPs on aquatic organisms are necessary 
(Brooks et al. 2005; Tang et al. 2006; Chu and Metcalfe 2007; Ramirez et al. 
2007; Berrada et al. 2008; Nakamura et al. 2008; Zhou et al. 2008; Ramirez et al. 
2009; Smith et al. 2009). 
On the basis of the complexity of environment matrices and the multiple 
functionalities of emerging contaminants as target compounds, recently 
described analytical protocols for the determination of PPCPs in both 
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wastewaters (Segura 2007; Lajeunesse et al. 2008; Segura 2009) and biological 
organisms (Tavazzi et al. 2002; Brooks et al. 2005; Chu and Metcalfe 2007; 
Berrada et al. 2008) have focused on rather specific classes of compounds. 
Antidepressants (Brooks et al. 2005; Chu and Metcalfe 2007; Lajeunesse et al. 
2008) and antibiotics (Segura 2007; Berrada et al. 2008; Segura 2009) are the 
two classes that have been studied the most. As the list of compounds found in 
field collected fish samples expands, the need to develop simultaneous 
screening methods for multiple classes of drug residues increases as well 
(Balmer et al. 2004; Duedahl-Olesen et al. 2005; Buser et al. 2006; Rudel et al. 
2006; Mottaleb et al. 2009). At present, the general approach employed for the 
analysis of multi-class pharmaceuticals in fish involves extraction of 
homogenized tissue with 1:1 mixture of 0.1 M acetic acid and methanol (Ramirez 
et al. 2007), or acetonitrile combined with limited cleanup to back-extract lipid 
material followed by liquid chromatography-mass spectrometry (LC-MS) analysis 
(Smith et al. 2009). Additionally, the use of solid-phase microextraction (SPME) 
techniques has also been explored as surrogates to estimate the potential 
occurrence and uptake of pharmaceuticals in living fish by assuming similar 
partition behavior between the SPME devices and the fish tissues placed in 
contaminated environments (Zhou et al. 2008). 
Accelerated solvent extraction (ASE) involving high pressure and temperature 
has been shown to efficiently extract a wide range of compounds from fish 
tissues (Draisci et al. 1998; Datta et al. 2002; Tavazzi et al. 2002; Wahlen 2004; 
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Chu and Metcalfe 2007; Haglund et al. 2007; Berrada et al. 2008; Llorca et al. 
2009; Losada et al. 2009; Lund et al. 2009). Meanwhile, HLB polymeric 
cartridges are routinely used as SPE sorbent for cleanup of complex 
environmental samples prior to LC-MS analysis. However, on the basis of 
considerable variation in lipophilicity and pKa among different classes of 
pharmaceuticals, optimum cleanup efficiency can be challenged by differential 
retention behavior of target analytes on the sorbent. In contrast, mixed-mode 
cation exchange (MCX) cartridges can accommodate both neutrals and cations 
providing better selectivity during elution steps. For instance, Chu et al (Chu and 
Metcalfe 2007) developed a method to determine paroxetine, fluoxetine and its 
metabolite in fish tissue using accelerated solvent extraction followed by MCX 
cleanup offering better recoveries and minimized matrix interferences. Because 
of the capabilities mentioned above, mixed-mode MCX cartridges will likely 
provide the needed retention for the multiple classes of pharmaceuticals 
proposed herein. 
The objectives of this study were to develop a comprehensive LC-MS/MS 
method for the analysis of pharmaceuticals representing multiple therapeutic 
classes in fish tissue, reclaimed and surface water, and to achieve better 
sensitivity and recoveries for the determination of pharmaceuticals in biological 
tissues by using a combination of accelerated solvent extraction followed by 
mixed-mode SPE cleanup and LC-MS/MS detection.  
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2.2 Experimental 
2.2.1 Reagents, standards and solutions 
The LC-MS grade methanol, water and formic acid used for mass spectrometry 
analysis and the Optima grade methylene chloride and acetonitrile used for ASE 
extraction were purchased from Fisher Scientific (Atlanta, GA). Distilled water for 
SPE cleanup was purified and deionized with a Barnstead Nanopure water 
purification system. Reference standards lincomycin, trimethoprim, caffeine, 
sulfamethoxazole, diphenhydramine, diltiazem, carbamazepine, fluoxetine, 
erythromycin, norfluoxetine and sertaline were purchased in the highest available 
purity (Sigma-Aldrich, Milwaukee, WI). Five surrogates, covering the range of 
functionalities were used for the method. Caffeine-13C3 was purchased from 
Cambridge Isotopes Lab. Inc. (Andover, MA). Sulfamethoxazole-d4, 
erythromycin-13C, d3 and paroxetine-d4 were purchased from Toronto Research 
Chemicals Inc. (North York, Ontario). Carbamazepine-d10 was purchased from 
C/D/N Isotopes Inc. (Pointe-Claire, Quebec). Fluoxetine-d6 was purchased from 
Cerilliant Corp. (Round Rock, TX). All stock solutions and working solutions were 
made in methanol and stored at -20°C in the dark to prevent degradation. The 
0.1% formic acid solution used for mobile phase was prepared daily before 
analysis. Ancillary solutions used as modifiers, i.e. acetic acid (pH 3.2), 5% 
ammonium hydroxide in methanol and methanol:0.1% formic acid 50:50 (v/v) 
were prepared daily.  
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2.2.2 Sample collection and storage 
Water and mosquito fish (Gambusia holbrooki) were collected from a freshwater 
pond and a saltwater marsh located at Florida International University Biscayne 
Bay Campus (North Miami Beach, FL). The saltwater tidal marsh is not impacted 
by reclaimed water and is hydrologically connected with Biscayne Bay while the 
freshwater pond is isolated from the tidal influence of the bay and continuously 
receives storm water runoff and reclaimed water from a local WWTP through 
daily sprinkler irrigation. Therefore, the organisms living in this pond are likely to 
be chronically exposed to the contaminants from reclaimed water. Seven 
composite mosquito fish samples were collected from each sampling site using 
unbaited minnow traps deployed at depth between 20 and 30 cm. The sizes of 
the fish collected in the traps ranged from 2.0-4.2 cm (total length) and 
individuals weighed from 0.3-2.1 g. All tissue samples were brought to the 
laboratory, sorted, classified and stored at or below -20 °C until time of analysis. 
Fish were pooled to obtain at least 30 g of material and homogenized with a 
ULTRA TURRAX IKA T18 stainless steel tissuemiser (Wilmington, NC) set to 
rotate at 10,000 rpm. The homogenates were stored at -20 °C and thawed at 4°C 
for approximately 10 h before extraction. Reclaimed water (1-Liter) was directly 
drawn from irrigation sprinklers during a period of two months, while pond water 
samples were collected in 1-Liter pre-cleaned amber glass bottles at the site 
where fish were collected. All water samples were transported to the laboratory 
and stored in dark at or below 4 °C until they were filtered and processed. Water 
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extraction was conducted within 7 days of collection to prevent losses on the 
basis of biodegradation. 
2.2.3 Animal care and use  
All animal experiments were conducted in accordance with the Institutional 
Animal Care and Use Committee of Florida International University (#A3096-01). 
2.2.4 Solid phase extraction for water samples 
To remove suspended materials, water samples were filtered through 0.5 µm 
pre-combusted glass fiber filters (GE Water & Process Technologies, Trevose, 
PA) within 24 h after collection. 50 µL of surrogate standards solution were 
added to each 250 mL of filtered reclaimed water or pond water sample. Oasis 
HLB (3cc/60mg, Waters Corp., Franklin, MA) cartridges were conditioned with 3 
mL of methanol followed by 3 mL of distilled water. Solid phase extraction was 
performed on an ALLTECH 12-port vacuum manifold (Deerfield, IL). After the 
samples had passed through the HLB cartridges, they were washed with 4 mL of 
5% methanol in water prepared daily. The analytes were eluted with 3 mL of 
methanol. Each methanol eluent was mixed with 50 µL of paroxetine-d4 internal 
standard solution and evaporated to dryness under a gentle stream of purified 
nitrogen gas. Dried residues were reconstituted with 200 µL of methanol:0.1% 
formic acid 50:50 (v/v). After brief sonication and vortex, the samples were ready 
for LC-MS/MS analysis. 
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2.2.5 ASE extraction for fish tissues 
Fish samples were extracted using a Dionex ASE 200 accelerated solvent 
extraction system (Dionex Corp., Sunnyvale, CA). 25 g of Na2SO4 were placed in 
the 33-mL stainless steel extraction cell containing a glass fiber filter in the outlet 
side. Approximately 1 g of fish homogenate was placed on top of the Na2SO4. 
Five surrogates including caffeine-13C3 (412.0 ng), Sulfamethoxazole-d4 (100.0 
ng), carbamazepine-d10 (29.5 ng), fluoxetine-d6 (31.0 ng), and erythromycin-13C, 
d3 (100.0 ng) were added to each sample. The cell was topped with another 
glass fiber filter, firmly capped and extracted. Methylene chloride was employed 
as the extraction solvent. The ASE conditions are as follows: oven temperature 
80°C; pressure 1500 psi; heat for 5 min; 1 static cycle; static time 10 min; flush 
volume 60% and purge for 120 sec. After each extraction cycle, 30 mL 
methylene chloride extract was flushed into a 60-mL glass vial and dried under 
gentle nitrogen stream. The dried extract was then reconstituted with 30 mL of 
acetic acid (pH 3.2) in water. The glass vial was sonicated for 10 min and the 
sample was ready for MCX-SPE cleanup.  
2.2.6 Cleanup for fish tissues 
3cc/60mg Oasis MCX cartridges (Waters Corp., Franklin, MA) were employed for 
the fish extract cleanup. The cartridges were conditioned with 3 mL of methanol 
followed by 3 ml of acetic acid in water (pH 3.2). Care was taken not to dry the 
cartridges during loading process. A cartridge flow rate of less than 1 mL/min 
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was operated under the vacuum of 20 psi. Once the samples had passed 
through the cartridges, they were washed with 2 mL acetonitrile and dried for 5 
min. The cartridges were then eluted with 3 mL of 5% ammonium hydroxide in 
methanol. 50 µL of paroxetine-d4 internal standard solution were added, and 
samples were dried using a centrifuge concentrator (Labconco Corp., Kansas 
City, MO). 200 μL of methanol:0.1% formic acid 50:50 (v/v) were added to each 
sample. After 10 min sonication and 1 min of vortex, samples were transferred 
and analyzed by LC-MS/MS. 
2.2.7 LC–MS/MS analysis 
The liquid chromatography system consists of a Thermo PAL CTC autosampler 
and a quaternary Thermo Scientific Accela pump. Analytes were separated on a 
Hypersil GOLD 50 x 2.1 mm, 3 μm particle size and 175 Å pore size column, 
from Thermo Scientific (Bellefonte, PA). A simple binary gradient consisting of A: 
0.1% formic acid in water (v/v) and B: 100% methanol was employed for 
chromatographic separation. The gradient was (methanol %): 0 min 3%, 4 min 
3%, 10 min 97%, 13 min 3% and 16 min 3%. The flow rate was maintained at 
300 μL/min. The injection volume was 20 μL.  
All the samples were analyzed with a Thermo TSQ Quantum Access triple 
quadrupole (QqQ) mass spectrometry equipped with a heated electrospray ion 
source (HESI). Tandem mass spectrometry detection was performed in selected 
reaction monitoring (SRM) mode. Collision energy (CE) and tube lens voltage for 
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each compound were optimized through direct infusion into mass spectrometer 
at concentration of 1 μg/mL and at the flow rate of 15 μL/min. Additional 
instrumental parameters for all analytes were as follows: Spray voltage at 3500 
V, Capillary temperature and Vaporizer temperature at 300 °C; Sheath gas (N2) 
and Aux gas (N2) at 30 arbitrary units; Ion sweep gas (N2) at 10 arbitrary units. 
Scan time was set to 0.5s. Precursor ions, product ions and SRM transition 
parameters are listed in Table 2.1.  
 
 
 
 
 
 
 
 
 
 
 
  
Table 2.1 SRM transition parameters 
Compounds SRM 1 
Collision 
energy 
(V) 
SRM 2 
Collision 
energy 
(V) 
lincomycin 407→126 31 407→359 18 
trimethoprim 291→230 24 291→260 25 
caffeine 195→138 18 195→110 21 
sulfamethoxazole 254→156 17 254→108 29 
diphenhydramine 256→167 15 256→152 40 
diltiazem 415→178 25 415→150 39 
carbamazepine 237→194 19 237→192 21 
erythromycin 717→540 18 717→558 15 
fluoxetine 310→148 8 310→44 12 
norfluoxetine 296→134 6 296→31 46 
sertraline 306→275 12 306→159 28 
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2.2.8 Matrix effects 
Matrix effects could have a severe detrimental effect in LC-MS/MS analysis 
especially when coupled with ESI sources (Vanderford et al. 2003; Segura 2007). 
Both signal suppression and enhancement are commonly observed on the basis 
of co-eluting matrix interferences. The exact mechanism still remains unknown 
but it has been widely discussed in previous work with respect to PPCPs 
(Vanderford et al. 2003; Renew and Huang 2004; Segura 2007).  
In order to evaluate matrix effects, replicates of clean fish tissues (1 g) were 
extracted and cleaned up as described above. One of the extracts was spiked 
with a known amount of analytes and surrogates and brought to a final volume of 
200 μL with methanol:0.1% formic acid (50/50, v/v). Simultaneously, a 
methanol:0.1% formic acid (50/50, v/v) solution spiked with the same 
concentration of analytes and surrogates was analyzed as a matrix-free 
reference sample. Matrix effects were evaluated using the following equation 
(Segura 2007): 
 
where Rm+s is the response ratio of the analyte in spiked matrix, Rm is the 
response ratio of the analyte in unspiked matrix and R0 is the response ratio of 
the analyte in matrix-free reference sample.  
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2.3 Results and Discussion 
The target compounds were selected based on the results of an EPA pilot study 
for PPCPs in fish tissue (EPA 2009) and a previously reported PPCP screening 
method (Ramirez et al. 2007). According to the EPA pilot study, carbamazepine, 
diltiazem, diphenhydramine, fluoxetine, norfluoxetine and sertraline have been 
detected in fish collected from 5 effluent-dominated streams in various regions of 
the United States. Ramirez et al. (Ramirez et al. 2007) have also reported the 
presence of diphenhydramine, diltiazem, carbamazepine and norfluoxetine in fish 
collected from an effluent-dominated stream in Texas. In addition to the target 
compounds mentioned above, other pharmaceuticals such as trimethorprim, 
caffeine, sulfamethoxazole and erythromycin that have been routinely detected in 
the reclaimed water used for ground irrigation at Florida International University 
Biscayne Bay Campus (North Miami Beach, FL) were also included in this study 
to assess potential accumulation from the reclaimed water (Wang and Gardinali 
2012). 
2.3.1 Mass spectrometry 
In order to achieve similar ionization behavior as those expected during real 
sample analysis, optimization of analyte responses was performed while the 
mobile phase was infused along with the standard solution through a tee 
connector at a speed of 50 μL/min. The most abundant molecular ion was 
selected as the precursor ion for that particular analyte. With the exception of 
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erythromycin, protonated [M+H]+ was found to be the most abundant precursor 
ion for all analytes. [M+H–H2O]+ was found to be the most abundant precursor 
ion for erythromycin which was in agreement with Hirsh et al.,(Hirsch et al. 1999) 
who showed that erythromycin has already lost a water molecule when present in 
the aquatic environment. Once the precursor ion has been identified, Q3 was 
scanned to define product ions and to optimize the collision energy for each 
compound. Two SRM transitions were selected to avoid false positives and to 
give 4 identification points in accordance with EU Commission Decision 
2002/657/EC (2009). All optimized parameters can be found in Table 1. 
Both electrospray ionization (ESI) and heated electrospray ionization (HESI) 
probes were tested to obtain optimal ionization efficiency. HESI is designed to 
use ESI in combination with heated auxiliary gas that transforms ions in solution 
into ions in the gas phase more efficiently. As shown in Figure 2.1, HESI probe 
showed at least 2-4 times improvement over ESI for all the compounds, in 
particular for early eluting compounds such as lincomycin, caffeine, and 
trimethoprim mainly because of better peak shapes and narrower peak width. 
Therefore, HESI was selected as the ion source in this study. 
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Figure 2.1 Representative chromatograms of all selected pharmaceuticals 
standards on HESI (A) and ESI (B) sources at the same spiking level 
 
2.3.2 Accelerated solvent extraction for fish tissues 
The most commonly used methods for extracting multiclass pharmaceuticals 
from fish tissues involve sonicating or vigorously shaking tissue homogenates 
with organic solvents such as acetonitrile and methanol followed by direct LC-MS 
analysis (Tang et al. 2006; Ramirez et al. 2007; EPA 2009; Smith et al. 2009). 
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However, in order to improve the extraction efficiency and method throughput, 
ASE was used because of its advantages over traditional methods, including 
automated extraction, higher recoveries, and smaller volume of extraction 
solvents (Draisci et al. 1998; Datta et al. 2002; Tavazzi et al. 2002; Wahlen 2004; 
Chu and Metcalfe 2007; Haglund et al. 2007; Berrada et al. 2008; Llorca et al. 
2009; Losada et al. 2009; Lund et al. 2009). The first challenge when developing 
ASE method is to choose the appropriate extraction solvent. Various solvents 
including methanol, acetone, acetonitrile, and methylene chloride were tested  for 
fish homogenate samples (1 g) fortified with all the analytes. The final selection 
of the extraction solvent was based on the “absolute recovery” calculated by 
subtracting the peak area of unspiked sample from that of the spiked sample. 
Absolute recoveries in different solvent systems are shown in Figure 2.2, where 
methylene chloride showed the highest absolute recoveries for all the analytes 
except for lincomycin and erythromycin. Other ASE conditions such as oven 
temperature, pressure, static time and cycles, heat-up time and flush volume 
were selected with slight modifications according to previously reported methods 
(Chu and Metcalfe 2007). 
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Figure 2.2 ASE solvent selection based on absolute recoveries 
2.3.3 SPE cleanup 
Although trace analysis at ng/g level can be achieved when using mass 
spectrometry as the detection method, matrix effects are still problematic on the 
basis of co-eluting matrix components during the extraction procedures without 
additional cleanup steps (Ramirez et al. 2007; EPA 2009). Gel permeation 
chromatography (GPC) is generally applied to remove lipid contents from 
biological tissues. However, this method requires large volume of organic solvent 
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and an extra cleanup step is still needed to make the sample suitable for LC-MS 
analysis (Chu and Metcalfe 2007). In contrast, mixed mode cation-exchange 
(MCX) SPE has been shown to be a successful alternative to cleanup 
complicated matrices such as fish tissues while still maintaining optimum 
recoveries of analytes with considerable ranges of  pKa and lipophilicity (Chu and 
Metcalfe 2007). MCX cartridges can provide much cleaner extract than regular 
HLB cartridges because organic solvents such as methanol or acetonitrile can be 
used to wash cartridges and eliminate interferences without losing the selectively 
retained analytes for further elution. The only requirement is that the samples 
need to be acidified in order for analytes to be retained on the sorbent by cation 
exchange reactions. In addition, care must be taken during the pH adjustment 
because analytes could be lost during the loading and washing steps if the pH is 
too low (Chu and Metcalfe 2007). On the basis of the fact that sulfamethoxazole 
has the lowest pKa of 5.8 among all the analytes (Qiang and Adams 2004), ASE 
extract was adjusted with acetic acid to pH 3.3 which is approximately 2 units 
below the pKa of sulfamethoxazole. Five solvents including methanol, 
acetonitrile, acetone, methylene chloride and hexane:methylene chloride (50/50, 
v/v) mixture were tested as the wash solvents. Individual analyte recoveries in 
each solvent system are plotted in Figure 2.3, where error bars represent 
standard deviations from average recoveries (n=3). Because acetonitrile is a 
stronger eluent  than methanol (Nelis 1983), higher recoveries were expected 
from the methanol wash. However, acetontitrile was found to be the most 
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effective solvent at removing interferences from the cartridge while offering 
maximum recovery and good overall precision.  
 
Figure 2.3 Averaged (n=3) individual analyte recoveries in each wash solvent 
system 
2.3.4 Matrix effects 
All compounds were analyzed for potential matrix effects in HESI positive mode 
and results are shown in Table 2.2 along with the statistically derived MDLs 
(n=7). Positive values indicate signal enhancement and negative values indicate 
signal suppression on the basis of the matrix effects. As shown in Table 2.2, 
caffeine and erythromycin showed moderate signal enhancements. Similar 
results were also observed by Ramirez et al. (Ramirez et al. 2007). Other 
compounds showed various degrees of signal suppression.  
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Table 2.2 Observed MDLs Matrix Effects and recoveries in fish tissue 
 MDL (ng/g) 
Ramirez’s MDL(ng/g) 
(Ramirez et al. 2007) 
Matrix Effects 
(%) 
Recovery (%) 
lincomycin 1.05 5.53 –38 ± 0.2 63 ± 8 
trimethoprim 1.03 2.15 –65 ± 1 83 ± 4 
caffeine 0.81 3.93 33 ± 3 64 ± 13 
sulfamethoxazole 0.84 2.29 –54 ± 1 44 ± 4 
diphenhydramine 0.08 0.05 –40 ± 1 85 ± 4 
diltiazem 0.11 0.12 –95 ± 1 60 ± 16 
carbamazepine 0.10 0.54 –26 ± 0.4 61 ± 0.5 
erythromycin 0.51 6.42 20 ± 0.5 28 ± 0.4 
fluoxetine 1.19 6.73 –5 ± 5 66 ± 12 
norfluoxetine 0.41 2.90 –42 ± 5 19 ± 10 
sertraline 0.26 3.57 –26 ± 2 80 ± 1 
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For water samples, matrix effects were evaluated using the same procedure as 
for fish tissues (Table 2.3). Organic matter in surface waters has shown to play 
an important role on matrix effects (Renew and Huang 2004). The overall results 
indicate that reclaimed water showed more pronounced effects than pond water 
for most of the compounds. Signal enhancement was observed on 7 compounds 
in reclaimed water samples while only 2 compounds showed signal 
enhancement in the pond water samples. 
2.3.5 Analytical performance 
Analyte concentrations in fish tissues were determined based on response 
factors (RFs) of the target compounds relative to the surrogate internal 
standards. This approach can be used for most trace analysis, as it doesn’t 
require blank matrix and greatly alleviates the signal suppression or 
enhancement arising from matrix effects that can affect the sensitivity and 
response of the mass spectrometer in unpredictable ways. 
Method detection limits (MDLs) were used to evaluate the analytical performance 
in different matrices and reported in Table 2.2 and Table 2.3. MDL represents the 
lowest concentration of the analyte that can be measured and reported with 99% 
confidence in a given matrix is greater than zero (1986). It has been discussed 
and generally assumed that experimentally derived MDLs in a given matrix are 
appropriate for establishing detection threshold in environmental analysis 
(Ramirez et al. 2007; Mottaleb et al. 2009; Ramirez et al. 2009).  
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Table 2.3 Observed MDLs matrix effects and recoveries in pond water and reclaimed water 
 
Pond Water  Reclaimed Water 
MDL 
(ng/L) 
Matrix 
Effects 
(%) 
Recovery 
(%) 
 
MDL 
(ng/L) 
Matrix 
Effects 
(%) 
Recovery (%) 
lincomycin 3.3 263±14 136±14  10.9 268±59 152±12 
trimethoprim 2.6 64±2 101±6  266 74±6 69±4 
caffeine 7.6 -7±6 101±8  348 33±6 75±13 
sulfamethoxazole 4.6 -14±3 104±5  67.5 9±4 94±14 
diphenhydramine 0.4 -41±0.8 82±1  53.1 -18±0.3 79±1 
diltiazem 0.2 -36±3 68±0.7  26.9 -49±4 83±0.2 
carbamazepine 1.5 -18±1 90±5  17.8 26±7 117±23 
erythromycin 15 -2±4 112±2  88.0 35±3 115±8 
fluoxetine 3.4 -3±4 95±6  5.0 7±0.9 86±0.1 
norfluoxetine 1.0 -44±2 32±2  1.8 -25±2 21±0.1 
sertraline 1.2 -9±3 56±0.6  4.9 -2±2 40±0.6 
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Seven replicates of 1 g of clean fish tissues (n=7) were spiked with an 
appropriate amounts of analytes (for spike levels see Table 2.4) and extracted as 
described above. Similarly, seven replicates of 250 mL pond water and 250 mL 
reclaimed water were spiked at the same level and subjected to the SPE-LC-
MS/MS analysis. MDLs were then calculated by multiplying the one-side 
student’s t-value at 99% confidence by the sample standard deviation derived 
from the concentrations of 7 replicate spiked samples (1986). Concentrations 
below MDLs were reported as “not detected”. Compared to the previous studies 
(Ramirez et al. 2007), the protocol demonstrated here offers cleaner fish extracts 
giving lower MDLs for 10 out of 11 selected compounds. The MDL for 
diphenhydramine was slightly higher but similar to the value reported by Ramirez 
et al. (Ramirez et al. 2007). Concentrations of diphenhydramine detected in fish 
tissues, however, were considerably higher than the calculated MDL. For water 
samples, MDLs in reclaimed water were significantly higher than those in pond 
water because of both a more complicated matrix and higher overall 
concentrations that produced larger standard deviations. The recoveries of 
norfluoxetine were found at 19% in fish, 32% in pond water and 21% in reclaimed 
water, respectively. The low recovery is likely on the basis of the lack of methyl 
group in norfluoxetine increasing the water solubility compared to fluoxetine.  
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Table 2.4 Fortification levels for matrix effect assessment, recovery calculation and MDL 
determination in fish tissues and water samples 
  fortification levels in fish tissues (ng/g)  fortification levels in water (ng/L) 
  
Matrix 
effect 
assessment 
Recovery 
calculation  
MDL 
determination 
 
 
Matrix 
effect 
assessment 
Recovery 
assessment 
MDL 
determination 
lincomycin  9.9 9.9 1.0  40.0 40.0 4.0 
trimethoprim  9.9 9.9 1.0  40.0 40.0 4.0 
caffeine  39.9 39.9 4.0  160 160 16.0 
sulfamethoxazole  39.9 39.9 4.0  160 160 16.0 
diphenhydramine  2.0 2.0 0.2  8.0 8.0 0.8 
diltiazem  2.0 2.0 0.2  8.0 8.0 0.8 
carbamazepine  4.0 4.0 0.4  16.0 16.0 1.6 
erythromycin  20.1 20.1 2.0  80.4 80.4 8.0 
fluoxetine  60.0 60.0 6.0  240 240 24.0 
norfluoxetine  30.0 30.0 3.0  120 120 12.0 
sertraline  19.9 19.9 2.0  80.0 80.0 8.0 
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2.3.6 Analysis of environmental samples 
Mosquito fish (Gambusia holbrooki) sampled from a saltwater marsh not 
influenced by reclaimed water and a freshwater pond affected by reclaimed water 
influence were analyzed for target analytes. Reclaimed water and pond water 
samples collected over a period of 2 months were also concurrently analyzed. 
Concentrations of target analytes in water samples are summarized in Table 2.5. 
73% of target compounds were consistently detected in reclaimed water 
samples. However, fluoxetine, diltiazem and erythromycin were not detected in 
the pond water influenced by reclaimed water. The possible explanation is that 
these compounds can be rapidly dissipated from the water phase as a result of 
adsorption to sediment where they seem to be persistent (Andrisano et al. 2001; 
Kwon and Armbrust 2005; Davis et al. 2006; Kwon and Armbrust 2006). 
Therefore, it is not surprising that neither fluoxetine nor diltiazem was detected in 
fish tissues in this study even though they have been reported to accumulate in 
fish (Brooks et al. 2005; Chu and Metcalfe 2007; Ramirez et al. 2007). As shown 
in Table 2.6, caffeine, diphenhydramine and carbamazepine were detected in 
fish tissues from the freshwater pond but no target compounds were detected in 
those from the saltwater marsh. Bioaccumulation factors for caffeine, 
diphenhydramine and carbamazepine in mosquito fish (Gambusia holbrooki) 
were calculated accordingly and found at 29 ± 26 , 821 ± 422 and 108 ± 144, 
respectively. The calculated BAF for carbamazepine was consistent with 
literature value (Vernouillet et al. 2010). All the resulting BAFs were higher than 
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those calculated based on log Kow (octanol/water partition coefficient) (Duffy and 
Jorgensen 2000) and EPA Kow based Aquatic BioAccumulation Model (KABAM) 
(1 for caffeine, 93 for diphenhydramine and 14 for carbamazepine) (2009; EPA 
2009). Upon plotting a graph of BAF vs log Kow, a positive relationship was 
observed (R2=0.5665) which was consistent with previously proposed theory 
(Gossett et al. 1983). While diphenhydramine and carbamazepine have been 
previously observed in fish tissues (Ramirez et al. 2007), potential accumulation 
of caffeine in fish is reported here for the first time.  
2.4 Conclusions 
This study presents the development of a new method for the analysis of 
selected pharmaceuticals in fish tissue, reclaimed water and surface water 
directly affected by reclaimed water. Compared to previous methods, accelerated 
solvent extraction followed by MCX mixed-mode SPE cleanup provided a better 
alternative on the basis of cleaner extracts giving lower method detection limits. 
73% and 45% of all target compounds were consistently detected in reclaimed 
water and surface water, respectively. Caffeine, diphenhydramine and 
carbamazepine were detected in mosquito fish from the freshwater pond directly 
affected by reclaimed water influence but they were not detected in those from 
the saltwater mash. Bioaccumulation factors for caffeine, diphenhydramine and 
carbamazepine in mosquito fish were also calculated and found at 29 ± 26, 821 ± 
422 and 108 ± 144, respectively. 
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Table 2.5 Summary of concentrations of target compounds in reclaimed water and pond 
water 
Compounds  
Reclaimed water (ng/L) n=17 
 
Pond water (ng/L) n=9 
 
Mean sd Max Min Median 
 
Mean sd Max Min Median 
             lincomycin 
 
ND 
 
ND ND ND 
 
ND 
 
ND ND ND 
trimethoprim 
 
338 273 920 16 254 
 
1.3 3.7 11 ND ND 
caffeine 
 
1476 1177 4315 53 1217 
 
81 48 172 23 63 
sulfamethoxazole 
 
241 128 409 3.0 263 
 
8.0 5.2 14 ND 10 
diphenhydramine 
 
89 48 179 6.3 77 
 
0.67 0.38 1.3 ND 0.62 
diltiazem 
 
29 30 111 ND 22 
 
ND 
 
ND ND ND 
carbamazepine 
 
97 55 229 20 83 
 
4.5 1.9 6.6 1.9 5.4 
erythromycin 
 
79 37 141 ND 88 
 
ND 
 
ND ND ND 
fluoxetine 
 
9.7 5.4 24 ND 9.7 
 
ND 
 
ND ND ND 
norfluoxetine 
 
ND 
 
ND ND ND 
 
ND 
 
ND ND ND 
sertraline 
 
ND 
 
ND ND ND 
 
ND 
 
ND ND ND 
 
  
ND: less than MDL 
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Table 2.6 Concentrations (ng/g) of target compounds detected in 
fish tissue (n=7) from the freshwater pond 
Compounds 
 
Mean sd Max Min Median 
       lincomycin 
 
ND 
 
ND ND ND 
trimethoprim 
 
ND 
 
ND ND ND 
caffeine 
 
1.3 1.6 4.5 ND 1.2 
sulfamethoxazole 
 
ND 
 
ND ND ND 
diphenhydramine 
 
0.55 0.27 0.97 0.08 0.59 
diltiazem 
 
ND 
 
ND ND ND 
carbamazepine 
 
0.20 0.25 0.66 ND 0.10 
erythromycin 
 
ND 
 
ND ND ND 
fluoxetine 
 
ND 
 
ND ND ND 
norfluoxetine 
 
ND 
 
ND ND ND 
sertraline 
 
ND 
 
ND ND ND 
              
ND: less than MDL 
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CHAPTER 3 
Improving sample throughput and reducing carryover by reprogramming 
the CTC autosampler for on-line LC-MS/MS analysis using the EQuan 
system 
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3.1 Introduction 
As the list of pharmaceutically active compounds being reported in various 
environmental matrices keeps growing, it is obvious that there is a need to 
develop new analytical techniques that are more effective at analyzing multiple 
components in a large number of samples in limited time (Balmer et al. 2004; 
Buser et al. 2006; Mottaleb et al. 2009). Various solid phase extraction (SPE) 
methods combined with GC-MS and GC-MS/MS (Sacher et al. 2001; Mottaleb et 
al. 2009; Ramirez et al. 2009), or more recently, LC-MS/MS (Renew and Huang 
2004; Lajeunesse et al. 2008; Wang and Gardinali 2012) have been successfully 
developed to identify and quantify multiple classes of pharmaceuticals in 
aqueous matrices. The SPE procedures used can be very effective at removing 
matrix components and concentrating samples to achieve desired sensitivity. 
However, the preparation requires processing large sample volumes commonly 
ranging from 200 mL to 1 L (Lajeunesse et al. 2008; Wang and Gardinali 2012), 
which makes it time consuming and laborious.  
In order to address the needs for lower detection limits and higher sample 
throughput, an on-line SPE coupled to mass spectrometry detection was 
developed to eliminate several preparation steps such as evaporation and 
reconstitution (Segura 2007; Garcia et al. 2009; Wang and Gardinali 2012). The 
new protocol was successfully applied to screening and detecting of a variety of 
environmental contaminants including pharmaceuticals, endocrine disruptors and 
groups of pesticides (Segura 2007; Garcia et al. 2009). More recently, on-line 
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SPE LC-MS/MS has become a more desired technique in routine analysis of 
aqueous samples, especially for samples that are time sensitive and need large 
injection volume.  
As shown in Figure 3.1, the time for a typical on-line SPE LC-MS/MS analysis 
consists of autosampler preparation time, sample withdraw time, SPE sample 
loading and elution time, and chromatography separation time. On the basis of 
the fact that loading speed is at 1 mL/min, total run times could be quite long 
when large sample volume (i.e. 20-50 mL) is used to improve detection limits. To 
shorten the time between injections, “look ahead” mode can be enabled so that 
the autosampler sets up for the next injection during the current run. Although the 
“look ahead” injection mode can be used to incorporate autosampler preparation 
and sample withdraw time into chromatography time, the sample is still aspired 
into the sample loop during the next run cycle. In addition, the dead volume of 
large sample loops (>5 ml) creates a considerable delay of gradient changes and 
increases the uncertainty of mobile phase mixing.  
In this chapter, default autosampler program commands were modified from 1-
draw sample, 2-move to injection port, 3-aspire sample, 4-inject and 5-washing to 
1-inject, 2-wait, 3-switch injection valve to load, 4-washing, 5-draw sample, 6-
move to injection port, and 7-aspire sample (Figure 3.2). The amount of time that 
the modified autosampler program took was compared with those needed for the 
default injection mode and “look ahead” mode. Efficiencies for the washing steps 
of injection syringe and sample loop which lead to carryover were also 
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investigated among the default autosampler program, look ahead, and the 
modified autosampler program for all the compounds in laboratory routine 
analysis of water samples. 
 
 
Figure 3.1 Comparison of run times among a typical program, look ahead and 
the modified program for a 20 mL on-line EQuan injection with 10 min separation 
time 
 
 
Preparation time Sample 
withdraw time
SPE loading  
& elution time separation time 
Typical program
Sample 
inject time
SPE loading  
& elution 
time
separation time 
Sample 
inject time
Preparation time Sample 
withdraw time
Look ahead
SPE loading  
& elution 
time
separation time 
Sample 
inject time
Preparation time Sample 
withdraw time
Modified program
1 min 4 min 4 min 5 min 10 min
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Figure 3.2 Valve configurations and CTC autosampler commands in a typical autosampler program and the new 
autosampler program
 44 
3.2 Experimental 
3.2.1 Reagents, standards and solutions 
The sources and stock solution preparation of all reference standards were the 
same as those described in Chapter 2. The LC-MS grade methanol, water and 
formic acid used for mass spectrometry analysis were purchased from Fisher 
Scientific (Atlanta, GA). The 0.1% formic acid solution used for mobile phase was 
prepared daily before analysis.  
3.2.2 Instrumentation 
A Thermo EQuan online SPE system was used in this study. The HPLC system 
consists of two pumps: Accela 1000 was used as the analytical pump and Accela 
600 was used as the loading pump (Thermo Scientific, San Jose, CA). A Hypersil 
GOLD 20 mm × 2.1 mm, 12 µm preconcentration column (Thermo Scientific, San 
Jose, CA) was used as the loading column. The analytical separation was carried 
out using a Hypersil GOLD column (150 mm × 3.0 mm, 3 µm). A CTC-PAL 
autosampler (Thermo Scientific, San Jose, CA) with “Macro editing” function 
enabled was equipped to perform 5 mL injections. The autosampler was 
reprogrammed by rearranging the “commands” in “Macros” which work as the 
building blocks of the autosampler program. All the samples were analyzed with 
a Thermo TSQ Quantum Access triple quadrupole (QqQ) mass spectrometry 
equipped with a heated electrospray ion source (HESI). Tandem mass 
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spectrometry detection was performed in selected reaction monitoring (SRM) 
mode. Instrument control and data acquisition was performed using the software 
Xcalibur 2.1 (Thermo Scientific, San Jose, CA).   
3.2.3 Working principle of EQuan system 
The scheme of a typical online SPE setup based on column-switching is shown 
in Figure 3.3. The working procedure consists of switching a 6-position divert 
valve on the mass spectrometer which is programmed by the data system to 
control the loading and elution of the two LC columns. At the “Load” position, 5 
mL of sample was injected into a 5 mL loop and then loaded onto the SPE 
column by the loading LC pump (Accela 600), followed by a wash step to remove 
interferences. The sample was preconcentrated and target compounds were 
retained on the SPE column while the rest of sample along with matrix was 
directed to waste. Next, the analytical pump equilibrated the analytical column 
with starting gradient conditions for the analytical run. Once the sample loading 
completed, the valve switched to the “Inject” position reversing the solvent flow 
through the loading column and back flushing analytes onto the analytical column 
for separation. After a certain amount of time depending upon the gradients, the 
switching valve returned to the load position to allow the loading column to be re-
equilibrated.  
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Figure 3.3 Scheme of on-line SPE EQuan system based on column-switching 
3.3 Results and discussions 
Despite having the advantages of improved detection limits and simpler sample 
preparation steps, on-line EQuan system still suffers from the problems 
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associated with extended injection volume if a typical injection program is used. 
First of all, insufficient washing of the sample loop can lead to carryover. This 
generally will not become an issue for small volume direct injections as the 
sample loop (10-50 µL) would have been thoroughly flushed many times by the 
mobile phase passing through it. On the other hand, the EQuan system consists 
of a sample loop that is so large (>5 mL) that the sample loop would not be 
completely flushed before the autosampler draws the next sample, which 
subsequently leads to carryover. Secondly, unlike the negligible dead time of a 
direct injection system, one should take into account the dead time that a large 
sample loop creates because it could be up to several minutes depending on the 
size of the sample loop and the flow rate of mobile phase. Lastly and most 
importantly, the total run time could be quite long when an even larger sample 
volume (e.g., 20 mL) is used to improve detection limits. An example of a 20 mL 
injection will be discussed below and the run times were compared among a 
typical autosampler program, look ahead and the modified program.  
As shown in Figure 3.1, a typical 20 mL on-line EQuan injection with a 10 min of 
separation time consists of 1 min of preparation time, 4 min of sample withdraw 
time, 4 min of sample inject time, and 5 min of SPE loading and elution time. 
Because this multi-sampling scheme can be quite time consuming, the ability to 
perform “look-ahead” injections allows for significant time savings. The 
autosampler will take the subsequent sample in sequence while the mass 
spectrometer is analyzing the previous sample. Although “look ahead” injections 
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can be used to incorporate autosampler preparation and sample withdraw time 
into chromatography time, a sample is still aspired into the sample loop during 
the next run cycle. In addition, “look ahead” does not modify the configuration of 
sample loop, thus the considerable gradient delay and potential carryover are still 
present.  
To address this situation, the current CTC autosampler program was modified 
from 1-draw sample, 2-move to injection port, 3-aspire sample, 4-inject and 5-
washing to 1-inject, 2-wait, 3-switch injection valve to load, 4-washing, 5-draw 
sample, 6-move to injection port, and 7-aspire sample (see Figure 3.2). With this 
program, the “inject” command simultaneously triggers both data acquisition and 
injection valve to switch to the inject position. The sample driven by the mobile 
phase is then loaded onto the loading column. After waiting for a period of time 
that is long enough for the entire sample to pass through the sample loop, the 
injection valve is switched back to the load position which shorts the sample loop 
out of the system. At this point, sample loop can be thoroughly flushed with 
strong organic solvents such as methanol and acetonitrile resulting a more 
efficient washing and less carryover. Once the syringe and sample loop have 
been washed with solvents, the autosampler takes the next sample and aspires it 
into the sample loop waiting for analysis. In each sequence, the first sample 
consisting of mobile phase is used to equilibrate the system and to clean the 
sample loop from previous users. For a 10 min-chromatography separation, up to 
34% run time could be saved compared to the typical program and up to 25% 
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when compared to the already optimized “look ahead” option. A total of 79% of 
the selected pharmaceuticals had less carryover when compared to the 
traditional on-line LC-MS/MS analysis. 
3.4 Conclusions 
The new program incorporates the autosampler preparation time, sample 
withdraw and aspiration time into the load and chromatography time, resulting in 
significantly shortened run time for longer sequences. For a 10 min-
chromatography separation, up to 34% and 24% of less run time can be saved 
than the typical program and “look ahead”, respectively. The greatly reduced 
dead volume of the system also prevents the delay of gradient changes and 
allows for more efficient washing of samples on the loading column before 
transferring to the analytical column. 
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CHAPTER 4 
Uptake and depuration of pharmaceuticals in reclaimed water by mosquito 
fish (Gambusia holbrooki): A worst case multiple exposure scenario 
(Jian Wang, Piero Gardinali, Environmental Toxicology and Chemistry, in press) 
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4.1 Introduction 
Human pharmaceuticals and their metabolites enter the environment primarily 
through wastewater discharge on the basis of the limited removal procedures in 
traditional wastewater treatment plants (WWTPs) (Daughton and Ternes 1999; 
Ruhoy and Daughton 2008). Although concentrations in environmental water 
bodies are typically at ng/L to low µg/L level, these organic pollutants may still 
pose risks to aquatic species under chronic long-term exposure (Owen et al. 
2007; Gunnarsson et al. 2008). For instance, after a 21-day exposure, fluoxetine 
was shown to induce vitellogenin in male fathead minnows (Pimephales 
promelas) at 28 ng/L and venlafaxine caused mortality of fathead minnows at 
concentration as low as 305 ng/L (Schultz et al. 2011). Similarly, plasma samples 
from the rainbow trout (Oncorhynchus mykiss) exposed to sewage effluents were 
analyzed for 25 pharmaceuticals, of which levonorgestrel was detected in fish 
plasma at concentrations (8.5-12 ng/mL) exceeding the human therapeutic 
plasma level (Fick et al. 2010). Because many aquatic species were shown to 
have similar physiological receptors to those the pharmaceuticals are originally 
intended to react with in humans (Owen et al. 2007; Gunnarsson et al. 2008), the 
data suggested a high risk of pharmacological effects on rainbow trout (Fick et al. 
2010). Another study concerning the uptake and depuration as well as 
bioconcentration factors (BCFs) of pharmaceuticals including moclobemide, 5-
fluoruracil, carbamazepine, diazepam, carvedilol and fluoxetine was conducted in 
freshwater shrimp (Gammarus pulex) and water boatman (Notonecta glauca) 
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after a 2-day uptake phase (Meredith-Williams et al. 2012). The results showed 
that BCFs in freshwater shrimp were significantly higher than those found in 
water boatman, implying that pharmaceuticals may possess even higher risks to 
smaller aquatic species as environmental pollutants.  Recently, I reported that 8 
pharmaceuticals including trimethoprim, caffeine, sulfamethoxazole, 
diphenhydramine, diltiazem, carbamazepine, erythromycin, and fluoxetine were 
consistently detected in reclaimed water used for daily irrigation at Florida 
International University Biscayne Bay Campus (North Miami Beach, FL) (Wang 
and Gardinali 2012; Wang and Gardinali 2012). All these pharmaceuticals are 
unintentionally released to a freshwater pond through daily irrigation and some of 
them partition and accumulate in mosquito fish (Gambusia holbrooki) living in this 
pond (Wang and Gardinali 2012). Therefore, it is expected that aquatic systems 
like this freshwater pond influenced by substantial inputs of reclaimed water may 
represent a good model to study the exposure of biological resources to mixtures 
of pharmaceuticals under relatively natural conditions (Brooks et al. 2006). 
In addition, pharmacokinetic data describing the uptake and depuration of 
pharmaceuticals by aquatic species are extremely limited compared to those in 
mammals (Paterson and Metcalfe 2008; Meredith-Williams et al. 2012), thus it is 
important to study the uptake and depuration rates in systems that may represent 
“worst case exposure” without compromising the environmental relevance (Fick 
et al. 2010). Most aquatic monitoring studies designed to simulate exposure 
under environmentally relevant concentrations were performed in artificially clean 
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matrices (Nakamura et al. 2008; Paterson and Metcalfe 2008; Hoang et al. 2011; 
Meredith-Williams et al. 2012), often with exposure concentrations still higher 
than those would be found under natural conditions by one or more orders of 
magnitude (Paterson and Metcalfe 2008; Hoang et al. 2011). Although this 
approach maximizes the chances of quantifying any compounds that might 
accumulate with confidence, results are often not in good agreement with those 
from the field (Nakamura et al. 2008; Paterson and Metcalfe 2008; Meredith-
Williams et al. 2012). Reclaimed water produced by conventional primary and 
secondary treatment offers good surrogacy for a worst case exposure scenario 
and could be used to predict the extent of bioconcentration and toxicological 
thresholds in aquatic organisms without resourcing to unrealistic concentrations 
(Paterson and Metcalfe 2008). Moreover, to my knowledge, this is the first study 
using a non-artificial exposure matrix to assess uptake and depuration kinetics 
and bioconcentration factors (BCFs) in a highly relevant aquatic species for 
South Florida protected environments. 
4.2 Materials and methods 
4.2.1 Reagents, standards and solutions 
LC-MS grade methanol, water and formic acid used for mass spectrometry 
analysis and SPE extraction, and the Optima grade methylene chloride used for 
ASE extraction were purchased from Fisher Scientific (Bridgewater, NJ). The 0.1% 
formic acid used as mobile phase was prepared daily. The sources for all 43 
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pharmaceuticals and surrogate standards along with key physicochemical 
parameters (Log Kow) are shown in Table 4.1. All stock solutions (100 ppm) and 
working solutions were made in methanol and stored in the dark at –20 °C. 
4.2.2 Organism husbandry and exposure conditions 
A total of 117 mosquito fish (Gambusia holbrooki) weighing from 0.13 to 1.45 
grams in mass and measuring from 2.5 to 5.2 cm in total length were purchased 
from Carolina Biological Supply Company (Burlington, NC). Upon arrival, all fish 
were maintained in two 70-Liter glass aquaria filled with dechlorinated tap water 
(approximately 60 fish in each aquarium) for 14 days at 26.1 ± 0.7 °C under a 
14:10h light:dark cycle. All experiments were conducted in accordance with the 
Institutional Animal Care and Use Committee of Florida International University 
(#A3096-01). In order to minimize the variability of concentrations in the 
reclaimed water and to avoid possible losses on the basis of photo-degradation, 
a total of 160 liters of reclaimed water were collected from the reclaimed water 
outlet at Florida International University Biscayne Bay Campus (North Miami, FL) 
and kept in dark at 16 °C. Water quality parameters including salinity, pH and 
dissolved oxygen were monitored throughout the experiments using an YSI 556 
MPS Multi Probe System (YSI Incorporated, Yellow Springs, Ohio).  
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Table 4.1 Identity, source and physicochemical parameters (Log Kow) for all compounds used in the study 
  Name Log KOW a Source 
An
al
yt
es
 
Naproxen 3.10 Sigma-Aldrich (Milwaukee, WI) 
Ibuprofen 3.79 Sigma-Aldrich (Milwaukee, WI) 
Diclofenac 4.02 MP Biomedicals, LLC. (Santa Ana, CA) 
Mefenamic acid 5.28 Sigma-Aldrich (Milwaukee, WI) 
Salicylic acid 2.24 Sigma-Aldrich (Milwaukee, WI) 
Codeine 1.28 Cerilliant Corp. (Round Rock, TX) 
Gemfibrozil 4.77 Sigma-Aldrich (Milwaukee, WI) 
Bezafibrate 4.25 Sigma-Aldrich (Milwaukee, WI) 
Phenobarbital 1.33 Sigma-Aldrich (Milwaukee, WI) 
Butalbital 1.87 Sigma-Aldrich (Milwaukee, WI) 
Fenofibrate 5.19 Sigma-Aldrich (Milwaukee, WI) 
Atorvastatin 6.36 American Radiolabeled Chemicals,Inc. (Saint Louis, MO) 
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Mevastatin 4.32 Sigma-Aldrich (Milwaukee, WI) 
Pravastatin 3.10 Sigma-Aldrich (Milwaukee, WI) 
Fluoxetine 4.65 Sigma-Aldrich (Milwaukee, WI) 
Paroxetine 3.95 Sigma-Aldrich (Milwaukee, WI) 
Sertraline 5.29 Sigma-Aldrich (Milwaukee, WI) 
Diazepam 2.70 Cerilliant Corp. (Round Rock, TX) 
Lorazepam 2.41 Cerilliant Corp. (Round Rock, TX) 
Carbamazepine 2.25 Sigma-Aldrich (Milwaukee, WI) 
Diphenhydramine 3.11 Sigma-Aldrich (Milwaukee, WI) 
Atenolol -0.03 Sigma-Aldrich (Milwaukee, WI) 
Sotalol -1.89 Toronto Research Chemicals Inc. (North York, Ontario) 
Metoprolol 1.69 Sigma-Aldrich (Milwaukee, WI) 
Propranolol 2.60 ACROS organics (Morris Plains, NJ) 
Betaxolol 2.98 Sigma-Aldrich (Milwaukee, WI) 
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Carazolol 2.66 Toronto Research Chemicals Inc. (North York, Ontario) 
Pindolol 1.48 Sigma-Aldrich (Milwaukee, WI) 
Nadolol 1.17 Sigma-Aldrich (Milwaukee, WI) 
Salbutamol 0.64 Sigma-Aldrich (Milwaukee, WI) 
Clenbuterol 2.00 Sigma-Aldrich (Milwaukee, WI) 
Enalapril 2.45 Sigma-Aldrich (Milwaukee, WI) 
Diltiazem 2.79 Sigma-Aldrich (Milwaukee, WI) 
Tamoxifen 6.30 ACROS organics (Morris Plains, NJ) 
Metronidazole -0.02 ACROS organics (Morris Plains, NJ) 
Clotrimazole 6.26 Sigma-Aldrich (Milwaukee, WI) 
Glibenclamide 4.79 Sigma-Aldrich (Milwaukee, WI) 
Caffeine 0.16 Sigma-Aldrich (Milwaukee, WI) 
Sulfamethoxazole 0.48 Sigma-Aldrich (Milwaukee, WI) 
Trimethoprim 0.73 Sigma-Aldrich (Milwaukee, WI) 
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Lincomycin 0.29 Sigma-Aldrich (Milwaukee, WI) 
Erythromycin 2.48 Sigma-Aldrich (Milwaukee, WI) 
Norfluoxetine 4.07 Sigma-Aldrich (Milwaukee, WI) 
Su
rr
og
at
e 
in
te
rn
al
 s
ta
nd
ar
ds
 
[2H3]Ibuprofen N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H10]Carbamazepine N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H3, 13C]Erythromycin N/A Toronto Research Chemicals Inc. (North York, Ontario) 
[13C3]Caffeine N/A Cambridge Isotopes Lab. Inc. (Andover, MA) 
[2H4]Sulfamethoxazole N/A Toronto Research Chemicals Inc. (North York, Ontario) 
[2H4]Diclofenac N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H3]Mefenaimic acid N/A Toronto Research Chemicals Inc. (North York, Ontario) 
[2H4]2-hydroxybenzoic acid N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H6]Codeine N/A Cerilliant Corp. (Round Rock, TX) 
[2H5]Atorvastatin N/A Toronto Research Chemicals Inc. (North York, Ontario) 
[2H3]Pravastatin N/A Toronto Research Chemicals Inc. (North York, Ontario) 
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[2H5]Diazepam N/A Cerilliant Corp. (Round Rock, TX) 
[2H4]Lorazepam N/A Cerilliant Corp. (Round Rock, TX) 
[2H7]Atenolol N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H3]Albuterol N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H5]Enalaprilat N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H5]Tamoxefen N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H4]Metronidazole N/A Toronto Research Chemicals Inc. (North York, Ontario) 
[2H5]Clotrimazole N/A C/D/N Isotopes Inc. (Pointe-Claire, Quebec) 
[2H11]Glyburide N/A Toronto Research Chemicals Inc. (North York, Ontario) 
[2H6]Fluoxetine N/A Cerilliant Corp. (Round Rock, TX) 
[2H6]Fenirofibrate N/A Toronto Research Chemicals Inc. (North York, Ontario) 
[2H5]Timolol N/A Toronto Research Chemicals Inc. (North York, Ontario) 
a Log Kow  values were calculated from EPI suite V4.0 KOWWIN V1.68 
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After the acclimation period, 84 mosquito fish were exposed to reclaimed water in 
a 70-Liter aquarium as exposure group. The exposure experiments consisted of 
a 7-day uptake phase with a daily 50% renewal of the reclaimed water. 
Approximately eight individual (7-9) mosquito fish and 280 mL of exposure water 
were collected for full chemical analysis on 0.2, 1, 2, 3, 5 and 7 days during the 
uptake phase. After the uptake phase was completed, the remaining fish were 
transferred to another aquarium filled with clean dechlorinated tap water and 
allowed to depurate for 14 days. 7-8 individual fish and 280 mL of the depuration 
water were collected on 1, 3, 6, 10 and 14 day during the depuration phase. 
Meanwhile, the remaining 33 fish were kept in a separate 70-Liter aquarium filled 
with clean tap water as control group. 10-13 mosquito fish and 280 mL of water 
in the control aquarium were collected on 0 and 7 day of the uptake phase and 
14 day of the depuration phase. 
Once removed from the aquarium, each fish was rinsed with deionized water to 
remove any pharmaceutical residue from its surface and euthanized with liquid 
nitrogen according to the approved IACUC plan. All fish collected at the same 
sampling event were grouped as one sample and homogenized with a ULTRA 
TURRAX IKA T18 stainless steel tissuemiser (Wilmington, NC) set to rotate at 
10,000 rpm. The homogenates were stored at –20 °C and thawed at 4 °C for 
approximately 10 hours before extraction. All water samples were filtered 
immediately after collection and stored in dark at or below 4 °C until they were 
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processed. Water extraction was conducted within 7 days of collection to prevent 
losses on the basis of biodegradation.  
4.2.3 Extraction of fish tissues 
Fish homogenates were extracted using a Dionex ASE 200 accelerated solvent 
extractor (Dionex Corp., Sunnyvale, CA) fitted with 33 mL stainless steel 
extraction cells. 25 grams of Na2SO4 were placed in the extraction cell containing 
a glass fiber filter in the outlet side. 1.95-3.16 grams of fish homogenate were 
placed on top of the Na2SO4. After adding 200 µL of surrogate solution 
containing 100 ng/mL of each surrogate standard, the cell was topped with 
another fiber filter, firmly capped and extracted with methylene chloride. The 
extraction conditions are as follows: oven temperature 80°C, pressure 1500 psi, 
heat for 5 min, 1 static cycle, static time 10 min, flush volume 60% and purge for 
120 sec. After each extraction cycle, 30 mL methylene chloride extract was 
flushed into a 60-mL glass vial and blown down to approximated 5 mL under 
gentle nitrogen stream. The concentrated extract was then quantitatively 
transferred to a 10-mL glass test tube and completely dried under gentle nitrogen 
stream. The dried extract was reconstituted with 200 μL of methanol:0.1% formic 
acid 10:90 (v/v). After 10 min sonication and 1 min of vortex, samples were 
transferred and analyzed by LC–MS/MS. 
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4.2.4 Extraction of water samples 
Immediately after collection, water samples were filtered through 0.5 µm pre-
combusted glass fiber filters (GE Water & Process Technologies, Trevose, PA) to 
remove suspended materials. 200 µL of surrogate solution containing 100 ng/mL 
of each surrogate standard were added to the samples which were subsequently 
extracted as described by Wang et al (Wang and Gardinali 2012). Briefly, Oasis 
HLB (3cc/60mg, Waters Corp., Franklin, MA) solid phase extraction cartridges 
were conditioned with 3 mL of methanol followed by 3 mL of distilled water. After 
the samples had passed through the HLB cartridges, analytes were eluted with 1 
mL of methanol. Each methanol eluent was evaporated to dryness under a 
gentle stream of nitrogen gas. Dried residues were reconstituted with 200 µL of 
methanol:0.1% formic acid 10:90 (v/v). After brief sonication and vortex, the 
samples were ready for LC–MS/MS analysis. 
4.2.5 LC–MS/MS analysis 
Liquid chromatography was performed on a quaternary Thermo Scientific Accela 
pump with a Thermo PAL CTC autosampler. A Hypersil GOLD 50 x 2.1 mm, 3 
μm particle size and 175 Å pore size column from Thermo Scientific (Bellefonte, 
PA) was used for separation. Two sets of mobile phases were used to 
accommodate target analytes in both positive and negative ionization modes. 
The mobile phases used for positive ionization mode consisted of A, 0.1% formic 
acid in water (v/v) and B, 100% methanol. The gradient was (methanol %): 0 min 
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3%, 2 min 3%, 8.5 min 97%, 15 min 3% and 17 min 3%. Acetonitrile and water 
were used for negative ionization mode. The gradient was (acetonitrile %):  0 min 
30%, 1 min 30%, 3 min 80%, 5 min 30% and 7 min 30%. A flow rate of 300 
μL/min was maintained for both gradients. The injection volume was set to 10 μL. 
All extracts were analyzed by a Thermo TSQ Quantum Access triple quadrupole 
(QqQ) mass spectrometry equipped with a heated electrospray ion source (HESI) 
operated in both positive and negative modes. Tandem mass spectrometry 
detection was performed in selected reaction monitoring (SRM) mode. Collision 
energy (CE) and tube lens voltage for each compound were optimized through 
direct infusion into mass spectrometer at concentration of 1 μg/mL and at the 
flow rate of 15 μL/min. Additional instrumental parameters for the target analytes 
in positive mode were optimized as follows: Spray voltage at 4000 V, Capillary 
temperature and Vaporizer temperature at 300 °C, Sheath gas (N2) and Aux gas 
(N2) at 30 arbitrary units, Ion sweep gas (N2) at 0 arbitrary units, and Scan time at 
0.02s. Similarly, the parameters in negative mode were set as follows: Spray 
voltage at 5000 V, Capillary temperature and Vaporizer temperature at 155 °C 
and 350 °C, respectively,  Sheath gas (N2) and Aux gas (N2) at 40 arbitrary units, 
Ion sweep gas (N2) at 0 arbitrary units, and Scan time at 0.05s. 
4.2.6 QA/QC samples 
Laboratory blanks and spiked blank samples were prepared to evaluate 
extraction recoveries in both fish and water. Concentrations in water and fish 
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samples were determined based on response factors (RFs) of the target analytes 
relative to the surrogate internal standards. This approach can be used for most 
trace analysis, as it doesn’t require a blank matrix and greatly alleviates the 
signal suppression or enhancement arising from matrix effects that can affect the 
sensitivity and response of the mass spectrometer (Wang and Gardinali 2012). 
Statistically derived method detection limits (MDLs) were used to evaluate the 
analytical performance in different matrices as they have been well-described 
and deemed appropiate for environmental analysis instead of signal to noise 
based limits of detection (LODs) (Ramirez et al. 2007; Ramirez et al. 2009; Wang 
and Gardinali 2012). Seven MDL replicate samples were prepared as described 
by Wang et al, (Wang and Gardinali 2012) and extracted as described above. 
Concentrations below MDLs are reported as “not detected”. 
4.2.7 Pharmacokinetics and bioconcentration analysis 
A one-compartment first order kinetics model was used to determine the 
depuration rate constants (kd) and corresponding half-lives (t1/2) (Barron et al. 
1990). Equation (1)-(3), used to solve kd and t1/2 , are as follows: 
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Where Cf is the concentration in the organism at time “t” during the depuration 
phase, and the constants a and b represent the slope and the intercept of 
equation (1), respectively.  
The uptake rate constant (ku) during the exposure phase was determined using 
the calculated depuration rate constant (kd) as outlined in equation (4) (Barron et 
al. 1990): 
 
Where Cf is the concentration in the organism at time “t”, and Cw is the 
concentration in water at the same time during the uptake phase.  
For comparison, the uptake was also analyzed using the Michaelis-Menten 
kinetics model (Hoang et al. 2011).  
 
Where KM is the Michaelis-Menten constant, Cf is the concentration in the fish at 
time “t”, and Csat is the concentration in the fish at saturated state (maximal 
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concentration). KM/Csat and 1/Csat are the slope and the intercept of equation (5), 
respectively. Csat can be determined by plotting 1/Cf over 1/t. 
Bioconcentration factors were evaluated by three different approaches. The 
steady-state bioconcentration factor was calculated using the concentration 
measure in the fish at 7 d of exposure (Cf) and the averaged water concentration 
(Cw) from all points taken during the uptake phase.  
 
The ratio of the uptake and depuration rate constants was calculated as the 
second bioconcentration factor.  
 
Lastly, a third value for the bioconcentration factor was calculated using Csat as 
derived from equation (5) using the averaged concentrations in water during the 
whole exposure time. 
 
4.3 Results and Discussions 
No significant changes in water quality parameters or fish mortalities were 
observed throughout the study. Temperature was maintained at 26.1 ± 0.7 °C, 
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dissolved oxygen was at 5.5 ± 0.6 mg/L, and pH was at 8.6 ± 0.2. No free 
chlorine was detected in any of the water samples. 
As shown in Table 4.2, a total of 26 pharmaceuticals ranging from 21.3 ng/L for 
fluoxetine to 8638 ng/L for caffeine were detected in the reclaimed water used in 
the exposure experiment. The relative standard deviation for exposure 
concentrations was less than 30.4 % in most cases, with exceptions for 
sulfamethoxazole at 48.2 %, and for naproxen at 52.4%, respectively. No target 
analytes were detected in control water or control fish at levels above the 
corresponding MDLs. 
Table 4.2 Pharmaceuticals detected in exposure reclaimed 
water  
Ionization 
mode 
Compound  
Concentration in 
reclaimed water 
(ng/L) 
RSD (%) 
(n=7) 
Positive Metronidazole 66.3 ± 11.1 16.8 
Positive Sotalol 594 ± 23.1 3.9 
Positive Salbutamol 68.8 ± 11.3 16.5 
Positive Atenolol 4605 ± 405 8.8 
Positive Codeine 201 ± 35.6 17.7 
Positive Trimethoprim 816 ± 109 13.3 
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Positive Caffeine 8638 ± 937 10.9 
Positive Nadolol 161 ± 35.3 22.0 
Positive Sulfamethoxazole 1152 ± 556 48.2 
Positive Metoprolol 196 ± 21.1 10.7 
Positive Propranolol 148 ± 33.2 22.4 
Positive Betaxolol 523 ± 34.1 6.5 
Positive Diphenhydramine 5218 ± 1350 25.9 
Positive Diltiazem 144 ± 43.7 30.4 
Positive Carbamazepine 1229 ± 112 9.1 
Positive Erythromycin 288 ± 45.6 15.8 
Positive Fluoxetine 21.3 ± 3.29 15.5 
Positive Lorazepam 117 ± 13.4 11.4 
Positive Tamoxifen 33.5 ± 1.6 4.7 
Positive Glibenclamide 115 ± 14.8 12.8 
Negative Phenobarbital 55.7 ± 12.5 22.5 
Negative Butalbital 126 ± 18.5 14.7 
Negative Naproxen 73.0 ± 38.2 52.4 
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Negative Diclofenac 958 ± 106 11.1 
Negative Ibuprofen 331 ± 35.8 10.8 
Negative Gemfibrozil 2272 ± 605 26.6 
 The observed concentrations for trimethoprim, caffeine, sulfamethoxazole, 
diphenhydramine, diltiazem, carbamazepine, erythromycin, and fluoxetine in 
reclaimed water were higher than those in previous reports (Wang and Gardinali 
2012; Wang and Gardinali 2012), in which reclaimed water was directly drawn 
from irrigational sprinklers. The mechanism for the loss in the reclaimed water 
drawn from sprinklers is unclear but is likely the results of different input sources. 
Therefore, the reclaimed water collected directly from the source outlet with 
higher concentrations was used here in order to maximize the chances of 
detecting more compounds that might be bioconcentrated by fish. Among the 26 
pharmaceuticals detected in reclaimed water, 5 pharmaceuticals including 
caffeine, diphenhydramine, diltiazem, carbamazepine, and ibuprofen were 
observed in mosquito fish as early as 5 h from the start of the exposure to 
reclaimed water. Uptake and depuration rate constants along with BCFs are 
summarized in Table 4.3 and shown in Figure 4.1. One-compartment first order 
and Michaelis-Menten kinetics models were fitted to the uptake and depuration 
curves. In general, both models fitted all uptake curves fairly well, while 
Michaelis-Menten kinetics model fitted the uptake curves better for caffeine 
(R2=0.9980), diphenhydramine (R2=0.9521), and carbamazepine (R2=0.9849), 
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whereas one-compartment first order model fitted the uptake curve better for 
diltiazem (R2=0.9871) and ibuprofen (R2=0.9812). All depuration curves 
appeared to follow first order elimination.  
Table 4.3 Uptake and depuration rate constants, half-lives and BCFs for 
selected pharmaceuticals in mosquito fish (Gambusia holbrooki) 
Compound  ku (mL g-1 h-1) kd (h-1) t1/2 (h) BCFa BCFb BCFc 
Caffeine 0.0011 0.0049 141 2.0 0.23 2.0 
Diphenhydramine 0.21 0.020 34 16 10 15 
Diltiazem 0.033 0.0059 117 16 5.6 16 
Carbamazepine 0.0085 0.0098 71 1.4 0.87 1.4 
Ibuprofen 0.64 0.022 32 28 29 27 
       4.3.1 Uptake and depuration kinetics 
The uptake of caffeine by mosquito fish was very rapid as the internal 
concentration reached the plateau and remained approximately constant after 5 
h of the exposure. Similar uptake behavior was also documented in Nile tilapia 
(Oreochromis niloticus) (Gomez-Martinez 2011). However, the depuration rate of 
caffeine in mosquito fish was much slower than that found in Nile tilapia, in which 
caffeine had a half-live of 4.95 h (Gomez-Martinez 2011) compared to the 141 h 
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for mosquito fish calculated in this study. The results indicate that caffeine would 
be uptaken by mosquito fish and Nile tilapia at relatively the same rate but 
remain in mosquito fish for a longer time and therefore, pose higher risks to 
mosquito fish than it does to Nile tilapia. For carbamazepine, the uptake rate 
constant (0.0085 mL g-1 h-1 or 0.20 L kg-1 day-1) and depuration rate constant 
(0.0098 mL g-1 h-1 or 0.24 L kg-1 day-1) in mosquito fish were similar to those 
reported in water boatman (Notonecta glauca) which were calculated at 0.29 L 
kg-1 day-1 and 1.2 L kg-1 day-1, respectively (Meredith-Williams et al. 2012). As a 
result, the rate constant-based BCF of 0.87 in mosquito fish was slightly higher 
than that of 0.24 in water boatman (Meredith-Williams et al. 2012). In contrast, a 
higher BCF for carbamazepine in freshwater shrimp (Gammarus pulex) was 
calculated at 7.1 in the same study (Meredith-Williams et al. 2012), and the value 
was 30 times and 8 times higher than that in water boatman and mosquito fish, 
respectively. The phenomenon that BCFs are organism size related has been 
previously discussed (Hendriks et al. 2001). The findings by Meredith-Williams et 
al. (Meredith-Williams et al. 2012) indicated that BCFs were indeed reduced as 
the organism size increased. Among the 5 pharmaceuticals detected in mosquito 
fish, diphenhydramine had the highest internal concentration of 82 ng/g that was 
reached after 77 h of the exposure to reclaimed water. During the depuration, 
diphenhydramine was quickly eliminated with the second shortest half live of 34 h. 
Similarly, a gradual uptake followed by a rapid depuration was observed for 
ibuprofen resulting the shortest half live (32 h) and the highest BCF among the 
five pharmaceuticals. Diltiazem followed a similar uptake curve as observed for 
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carbamazepine but the half-life (117 h) was longer than that of carbamazepine 
(71 h). Published data on the pharmacokinetics of diphenhydramine, diltiazem, 
and ibuprofen in aquatic organisms are limited, but data are available on BCFs of 
these compounds which will be compared below.  
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Figure 4.1 Uptake and depuration curves for mosquito fish (Gambusia holbrooki) 
exposed to reclaimed water: the dotted lines represent for the Michaelis-Menten 
curve fit and the solid lines represent for the first order curve fit 
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4.3.2 Bioconcentration factors 
In Table 4.3, BCFb ranged from 0.23 to 29 and increased in the order of caffeine 
< carbamazepine < diltiazem < diphenhydramine < Ibuprofen. BCFa and BCFc 
ranged from 2.0 to 28, and increased in the order of carbamazepine < caffeine < 
diltiazem < diphenhydramine < Ibuprofen. BCFs found for caffeine, 
diphenhydramine, and carbamazepine in mosquito fish were respectively lower 
than those reported from the previous study for natural exposure in the pond 
influenced by irrigation with reclaimed water (29 for caffeine, 821 for 
diphenhydramine, and 108 for carbamazepine) (Wang and Gardinali 2012). The 
lower BCFs in the laboratory experiment with full strength reclaimed water could 
possibly be related to the availability of additional dietary routes for the mosquito 
fish in natural settings (Blanco et al. 2004). In addition, the pond system may 
contain higher concentration of dissolved organic carbon (DOC) that has been 
shown to significantly enhance the BCFs of organic pollutants (Pickhardt et al. 
2006). Despite the known effects of acid base equilibrium on BCFs for ionizable 
compounds (Nakamura et al. 2008), the pH was not believed to have significant 
effects on the BCFs in this study because the pH of 8.6 in reclaimed water was 
similar to that in the fresh water pond (Wang and Gardinali 2012). BCFs 
calculated for carbamazepine, diltiazem, and ibuprofen in this study were in 
reasonably good agreement (within one order of magnitude) with plasma BCFs 
reported in the rainbow trout (Oncorhynchus mykiss) after exposed to treated 
sewage effluents (Fick et al. 2010). BCFs for carbamazepine in mosquito fish 
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(ranging from 0.87 to 1.4) were also in agreement with tissue BCF of 0.52 in 
rainbow trout (Zhang et al. 2010). Ibuprofen however, appeared to 
bioconcentrate less in rainbow trout (BCF of 1.5) (Zhang et al. 2010) than it did in 
mosquito fish (BCF of 29) in this study. Upon reviewing the literature (Brooks et 
al. 2005; Chu and Metcalfe 2007; Nakamura et al. 2008; Paterson and Metcalfe 
2008), fluoxetine, one of the most widely found pharmaceuticals in fish was not 
detected in any of the fish samples even though it was detected in the exposure 
reclaimed water at a concentration of 21.3 ± 3.29 ng/L in this study. This is not 
surprising because the concentration of fluoxetine in fish would be slightly above 
the MDL of 1.2 ng/g (Wang and Gardinali 2012) even if it bioconcentrated based 
on the highest BCF value reported at 80 (Paterson and Metcalfe 2008). 
Lastly, when constructing graphs (Figure 4.2) of calculated BCFs vs Log Kow, 
excellent positive relationships were observed for all compounds, with the 
exception of caffeine that had to be excluded from the plots. This behavior is 
consistent with previously proposed predictive models (Gossett et al. 1983). The 
abnormal behavior of caffeine was probably on the basis of its extreme Log Kow 
value of –0.07 (Stackelberg et al. 2007), thus caffeine most likely reached 
equilibrium between water and fish tissue instead of bioconcentration.  
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Figure 4.2 Correlations between bioconcentration factors and Log Kow (BCFa: 
based on steady state concentrations, BCFb: based on rate constants, and BCFc: 
based on saturation state concentrations) 
4.4 Conclusions 
This study described the pharmacokinetics and bioconcentration of 5 
pharmaceuticals in mosquito fish under the “worst case” exposure scenario. The 
results showed that some pharmaceuticals such as diphenhydramine could be 
accumulated in fish up to 82 ng/g while some pharmaceuticals such as caffeine 
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will rather equilibrate with the surrounding waters and would persist for a period 
of several days. The study also showed that a number of other compounds 
detected in rather high concentrations (e.g. diclofenac and gemfibrozil) did not 
accumulate in fish despite having moderately high Log Kow values implying that 
other mechanisms may have played a role in keeping them in solution. Because 
many aquatic species have similar physiological receptors to those originally 
targeted for pharmacological effects in humans (Owen et al. 2007; Gunnarsson 
et al. 2008), non-target species under chronic exposure may show potential 
adverse effects (Berninger and Brooks 2010; Fick et al. 2010). Therefore, future 
studies focused on biotransformation and metabolism in fish particularly targeting 
compounds with long persistence would provide useful information for predicting 
toxic effects in fish.   
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CHAPTER 5 
Identification of phase II pharmaceutical metabolites in reclaimed water 
using high resolution benchtop Orbitrap mass spectrometry 
(Manuscript ready for submission to Analytical Chemistry, 2013) 
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 5.1 Introduction 
Pharmaceutically active compounds are now well-acknowledged pollutants in the 
environment, especially in surface water and wastewater. They are released into 
the environment largely through the discharge of wastewater treatment plants 
(WWTPs) as a result of excretion and metabolism by humans and animals, and 
additionally disposal of unused or expired drugs (Daughton and Ternes 1999; 
Miao and Metcalfe 2003; Vanderford et al. 2003). Many studies have 
demonstrated that pharmaceuticals may pose adverse effects to wildlife and 
humans (drinking water) under chronic long-term exposure despite the relatively 
low concentrations in the environment (Vanderford et al. 2003; Brooks et al. 
2005). Therefore, it is not surprising that much attention regarding 
pharmaceuticals in the environment has been drawn on the basis of ecological 
concerns and public health.  
The presence of pharmaceutically active compounds in the environment is 
assessed largely by measuring the parent drugs (i.e., carbamazepine and 
fluoxetine) and to a lesser extent transformation products (i.e., 10,11-dihydro-
10,11-dihydroxycarbamazepine, the major metabolite of carbamazepine, and 
norfluoxetine, the major metabolite of fluoxetine) (Miao and Metcalfe 2003; 
Brooks et al. 2005; Miao et al. 2005; Chu and Metcalfe 2007). Parent drugs can 
be excreted as the unchanged form (Miao et al. 2005) whereas transformation 
products can be formed as metabolites by undergoing chemical or biochemical 
transformations (Gobel et al. 2004) or as photodegradation products by exposure 
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to sunlight (Bonvin et al. 2012). Parent drugs can undergo a broad range of 
reactions during metabolism which can be categorized into two phases (Murphy 
2001). Phase I reactions including oxidation, reduction and hydrolysis convert the 
parent drug into a more polar metabolite by adding or revealing functional groups 
such as –OH, –SH, –NH2 and –COOH, etc.. The mechanism involves a variety of 
enzymes such as cytochrome P450 oxidase and NADPH-cytochrome P450 
reductase introducing reactive and polar groups into their substrates (Lu et al. 
1969; Guengerich and Johnson 1997; Danielson 2002; Gu et al. 2003). The 
conversions including benzene to phenol (Schultzen and Naunyn 1867) and 
benzaldehyde to benzoic acid (Wohler and Frerichs 1848) were among the very 
first pieces of evidence indicating the ability of the body to oxidize xenobiotic 
compounds. Phase II metabolism is a conjugation reaction catalyzed by a large 
group of broad-specificity transferases (Williams 1947). Parent drugs and active 
metabolites are often conjugated with charged species such as glutathione 
(GSH), sulfate, glycine, or glucuronic acid to be detoxified (Chen et al. 2005; 
Berthiller et al. 2006; Holcapek et al. 2008). Current research is focusing heavily 
on unchanged parent drugs (Celiz et al. 2009). However, it is important to realize 
that the exposure to metabolites may have hazardous effects similar to those of 
the parent drugs (Bedner and MacCrehan 2006).  
Numerous analytical instruments have been applied to investigate the 
occurrence of parent drugs in a variety of environmental matrices (Vanderford et 
al. 2003; Davis et al. 2006; Kwon and Armbrust 2006; Ramirez et al. 2007; 
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Schultz et al. 2010; Wang and Gardinali 2012). Liquid chromatography coupled 
with triple quadrupole (QqQ) and to a lesser extend ion trap mass spectrometry 
is undoubtedly the most used approach in such targeted analysis. With the aids 
of high sensitivity and selectivity that tandem mass spectrometry offers when 
encountering complex matrices, most parent drugs can be detected and 
quantified at lower ng/L or ppt level (Miao and Metcalfe 2003; Miao et al. 2005; 
Lajeunesse et al. 2008; Wang and Gardinali 2012). In contrast, little attention has 
been paid to the identification, let alone quantification, of pharmaceutical 
metabolites (Celiz et al. 2009) because there could be numerous metabolites 
from one parent drug and it is also practically impossible to purchase or 
synthesize standards for all the metabolites. An addition consideration is the 
economical unsoundness of purchasing the standards for all metabolites. As a 
result, current targeted analysis of metabolites using tandem mass spectrometry 
is only limited to pharmaceuticals whose metabolites are well “known” from 
clinical data and standards for the metabolites are readily available to confirm the 
identity (Miao and Metcalfe 2003; Gobel et al. 2004; Miao et al. 2005). However, 
the increasing number of studies reporting the presence of metabolites in the 
environment underlines the urge to include non-target or unknown metabolites as 
an important part of routine analysis of pharmaceuticals. For instance, several 
LC-MS methods have been developed to determine carbamazepine, one of the 
most frequently detected pharmaceuticals in WWTP effluents and surface water, 
along with its major phase I metabolites in aqueous samples (Miao and Metcalfe 
2003; Miao et al. 2005). Interestingly, metabolite 10,11-dihydro-10,11-
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dihydroxycarbamazepine was found to be the dominant analyte which had a 
concentration 3 to 4 times higher than that of carbamazepine in wastewater 
(Miao and Metcalfe 2003). A significant increase of the parent drug was also 
observed in the treated wastewater effluent relative to concentrations in the 
untreated wastewater influent, suggesting that some phase II metabolites could 
have been transformed to the free form by cleavage of the conjugates during the 
treatment. The increase of the parent drug is likely related to the fact that 
hydroxylated metabolites of carbamazepine occur primarily in conjugated forms 
such as glucuronidation in body fluids (Miao et al. 2005).  A more recent study 
provided the first evidence that phase II metabolites of sulfamethoxazole existed 
and could be back-transformed to its parent drug under abiotic conditions, 
indicating that these phase II metabolites may survive wastewater treatment and 
serve as an additional environmental source of sulfamethoxazole (Bonvin et al. 
2012). Therefore, it is increasingly important to include phase II metabolites when 
assessing the occurrence, fate and transport of pharmaceuticals in the 
environment. 
In recent years, high resolution mass spectrometry including time of flight (TOF) 
and Orbitrap has become a powerful tool at identifying “unknown” metabolites in 
both metabolomics and environmental studies (Lim et al. 2007; Ferrer and 
Thurman 2010; Calza et al. 2012; Thurman and Ferrer 2012). Operated at a 
resolving power > 40,000, mass accuracy < 5 ppm is normally achievable on 
modern TOF instruments allowing positive identification based on accurate mass 
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measurements. Difficulties associated with using TOF instruments are the limited 
dynamic range and the dependence on lock mass or internal calibration to 
maintain high mass accuracy (Petrovic et al. 2006; Ibanez et al. 2012). In 
contrast, external calibration can be used for Orbitrap instruments to obtain 
excellent mass accuracy (<3 ppm) resulting a simplified operational protocol (Lim 
et al. 2007). In addition, Orbitrap instruments offer better dynamic range and 
sensitivity close to those of many triple quadrupole instruments. The features that 
Orbitrap offers are especially important for environmental analysis when the 
concentrations are not sufficiently high compared to those in metabolic or 
pharmacokinetic studies (Peterman et al. 2006).  
The objectives in this study were to identify phase II metabolites in reclaimed 
water using a Q Exactive Orbitrap mass spectrometer based on accurate mass 
measurements combined with characteristic ions from MS/MS data dependent 
scans, and to determine the concentrations of identified phase II metabolites 
relative to their parent drugs in reclaimed water. 
5.2 Experimental 
5.2.1 Chemicals and Standards 
Reference standards of pharmaceuticals, two metabolites (norfluxetine and O-
desmethyltramadol) and isotopically labeled standards were purchased from 
Sigma-Aldrich (Milwaukee, WI), MP Biomedicals, LLC. (Santa Ana, CA), 
Cerilliant Corp. (Round Rock, TX), American Radiolabeled Chemicals,Inc. (St 
 86 
Louis, MO), Toronto Research Chemicals Inc. (North York, Ontario), ACROS 
organics (Morris Plains, NJ), C/D/N Isotopes Inc. (Pointe-Claire, Quebec) and 
Cambridge Isotopes Lab. Inc. (Andover, MA). Details of the sources of standards 
were also shown in Table 4.1. All standards presented purity higher than 95%. 
Pierce LTQ Velos ESI positive ion and negative ion calibration solutions (Thermo 
Scientific, Rockford, IL) for Q Exactive orbitrap mass spectrometer were provided 
by Thermo Scientific (Rockford, IL). LC-MS grade methanol, water and formic 
acid were purchased from Fisher Scientific (Bridgewater, NJ). The 0.1% formic 
acid used as mobile phase was prepared daily. All stock solutions (100 ppm) and 
working solutions were made in methanol and stored in the dark at –20 °C.  
5.2.2 Sample Collection 
During a period of one month, reclaimed water (500 mL) was directly drawn from 
the reclaimed water outlet at Florida International University Biscayne Bay 
Campus (North Miami, FL). Polyethylene terephthalate bottles (500 mL) were 
used to collect water samples and rinsed with the sampling water three times 
before the samples were taken. Water samples were filtered and stored in dark 
at or below 4 °C until processed. Head space was minimized by filling the bottles 
completely. Water extraction was conducted within 7 days of collection to prevent 
changes associated with biodegradation.  
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5.2.3 Sample Extraction 
To remove suspended materials, water samples were filtered through 0.5 µm 
pre-combusted glass fiber filters (GE Water & Process Technologies, Trevose, 
PA) within 24 h after collection. Each water sample was extracted with an Oasis 
HLB (3 cc/60 mg, Waters Corp., Franklin, MA) cartridge coupled in tandem to a 
Sep-Pak tC18 Plus cartridge (900 mg, Waters Corp., Franklin, MA). The 
combination of two different sorbent materials was used to ensure high 
recoveries of the metabolites (Eichhorn et al. 2005). Both cartridges were 
conditioned together with 5 mL of methanol followed by 5 mL of distilled water. 
Solid phase extraction was performed on an ALLTECH 12-port vacuum manifold 
(Deerfield, IL). After the samples had passed through the cartridges, the analytes 
were eluted with 3 mL of methanol. The methanol eluent was evaporated to 
dryness under a gentle stream of purified nitrogen gas. Dried residues were 
reconstituted with 200 µL of methanol:0.1% formic acid 50:50 (v/v). After brief 
sonication and vortex, the samples were ready for LC-MS analysis. 
5.2.4 Liquid Chromatography and Q Exactive Mass spectrometry 
 Liquid chromatography was performed on a quaternary Thermo Scientific Accela 
pump with a Thermo PAL CTC autosampler. A Hypersil GOLD 50 x 2.1 mm, 3 
μm particle size and 175 Å pore size column from Thermo Scientific (Bellefonte, 
PA) was used for separation. Two sets of mobile phases were used for both 
positive and negative ionization modes. The mobile phases used for positive 
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ionization mode consisted of A, 0.1% formic acid in water (v/v) and B, 100% 
acetonitrile. Acetonitrile and water were used for negative ionization mode. The 
gradient remained the same for both ionization modes, which was (acetonitrile 
%): 0 min 3%, 2 min 3%, 8.5 min 97%, 15 min 3% and 17 min 3%. A flow rate of 
300 μL/min was maintained for both gradients. The injection volume was set to 
10 μL. 
All extracts were analyzed by a Q Exactive Orbitrap mass spectrometer (Thermo 
Scientific, San Jose, CA) equipped with a heated electrospray ion source (HESI-
II) operated in both positive and negative modes. As a part of routine 
maintenance, the instrument was calibrated weekly using Pierce LTQ Velos ESI 
Positive Ion and Negative Ion Calibration Solutions (Thermo Scientific, Rockford, 
IL) for positive and negative modes, respectively. Mass accuracy less than 0.6 
ppm was always achieved from the external calibration that was performed prior 
to analysis or every 24 hours. Ultra-pure nitrogen and argon were used as ion 
source gas and collision gas, respectively. Mass spectrometry parameters in 
positive mode were set as follows: Sheath gas, Aux gas and Sweep gas were at 
35, 35 and 5 arbitrary units, respectively. Similarly, the parameters in negative 
mode were set as follows: Sheath gas, Aux gas and Sweep gas were at 40, 20 
and 5 arbitrary units, respectively. The following parameters remained the same 
for both positive and negative modes: Spray voltage was at 4 kV. Capillary 
temperature and Vaporizer temperature were at 300 °C. The data-dependent 
scan cycle included a full scan operated at a resolving power of 70,000 with a 
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scan range from 80-1000 m/z and three corresponding data-dependent MS/MS 
scans acquired at resolving power of 35,000. The three most abundant precursor 
ions triggered data-dependent scanning and were subsequently injected to the 
C-trap to be fragmented. Isolation window for MS/MS scanning was set to 2 m/z. 
Normalized collision energy (NCE) was set to 35 with stepped NCE of 25%.  
5.2.5 Data Interpretation 
The calculation of exact masses from elemental compositions was carried out 
using MetWorks 1.3 (Thermo Scientific, San Jose, CA). High resolution extracted 
ion chromatograms (XICs) of the parent pharmaceutical and its potential phase II 
metabolites were obtained by processing the full scan data using MetWorks with 
a 5 ppm mass tolerance. Data-dependent spectra of the positively identified 
compounds were further investigated by Mass Frontier 7.0 (Thermo Scientific, 
San Jose, CA) using the Fragment Ion Search (FISh) feature, in which theoretical 
spectra generated from chemical structures were compared with those observed 
from the experiment. Similarities between the theoretical and observed spectra, 
along with isotope patterns, even electron species and rings plus double bonds 
(RDB) values were considered to aid the assignment of metabolite identification. 
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5.3 Results and discussions 
5.3.1 Performance of Q Exactive Orbitrap 
Table 5.1 shows the selected pharmaceuticals routinely monitored in reclaimed 
water as described in previous studies. The performance of accurate mass 
measurements in external calibration mode was investigated by injecting 10 μL of 
the mixture of all parent pharmaceutical standards at 200 ng/mL immediately 
after calibration and at the end of each sequence up to 16 h post-calibration. The 
observed accurate masses were systematically lower than exact masses for the 
majority of compounds, but the mass accuracy never exceeded 2.9 ppm except 
for naproxen which was calculated at -3.9 ppm (Table 5.1). Mass accuracy was 
also evaluated for the standards injected at the end of each sequence. Mass 
accuracy of 4 ppm or better was always achieved for all compounds after up to 
16 h post-calibration (data not shown). The values for mass accuracy were better 
than those obtained from most time-of-flight mass spectrometers in internal 
calibration mode (Petrovic et al. 2006; Ferrer and Thurman 2010; Thurman and 
Ferrer 2012). 
Table 5.1 Elemental compositions, exact masses, observed accurate 
masses, and mass accuracy of selected parent pharmaceuticals  
 
Name 
Elemental 
Composition 
Exact 
Mass (m/z) 
Observed 
Accurate 
Mass (m/z) 
Mass 
Accuracy 
(ppm) 
  
 
Atenolol C14H22N2O3 267.1703 267.1696 -2.6 
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Atorvastatin C33H35FN2O5 559.2603 559.2593 -1.8 
 
 
Betaxolol C18H29NO3 308.2220 308.2213 -2.3 
 
 
Bezafibrate a C19H20ClNO4 360.1008 360.1011 0.8 
 
 
Butalbital a C11H16N2O3 223.1088 223.1085 -1.3 
 
 
Caffeine C8H10N4O2 195.0877 195.0873 -2.1 
 
 
Carazolol C18H22N2O2 299.1754 299.1747 -2.3 
 
 
Carbamazepine C15H12N2O  237.1022 237.1017 -2.1 
 
 
Clenbuterol C12H18Cl2N2O 277.0869 277.0863 -2.2 
 
 
Clotrimazole C22H17ClN2 345.1153 345.1146 -2.0 
 
 
Codeine C18H21NO3 300.1594 300.1588 -2.0 
 
 
Diazepam C16H13ClN2O 285.0789 285.0785 -1.4 
 
 
Diclofenac a C14H11Cl2NO2 294.0094 294.0097 1.0 
 
 
Diltiazem C22H26N2O4S 415.1686 415.1677 -2.2 
 
 
Diphenhydramine C17H21NO 256.1696 256.1690 -2.3 
 
 
Enalapril C20H28N2O5 377.2071 377.2062 -2.4 
 
 
Enalaprilat C18H24N2O5 349.1758 349.1751 -2.0 
 
 
Erythromycin C37H65NO12 716.4580 716.4562 -2.5 
 
 
Fenofibrate C20H21ClO4 361.1201 361.1191 -2.8 
 
 
Fluoxetine C17H18F3NO 310.1413 310.1409 -1.3 
 
 
Furosemide a C12H11ClN2O5S 329.0004 329.0009 1.5 
 
 
Gemfibrozil a C15H22O3 249.1496 249.1495 -0.4 
 
 
Glibenclamide C23H28ClN3O5S 494.1511 494.1503 -1.6 
 
 
Ibuprofen a C13H18O2 205.1234 205.1228 -2.9 
 
 
Ketoprofen a C16H14O3 253.0870 253.0873 1.2 
 
 
Lincomycin C18H34N2O6S 407.2210 407.2202 -2.0 
 
 
Lorazepam C15H10Cl2N2O2 321.0192 321.0186 -1.9 
 
 
Mefenamic acid a C15H15NO2 240.1030 240.1030 0.0 
 
 
Metoprolol C15H25NO3 268.1907 268.1902 -1.9 
 
 
Metronidazole C6H9N3O3 172.0717 172.0713 -2.3 
 
 
Mevastatin C23H34O5 391.2479 391.2471 -2.0 
 
 
Nadolol C17H27NO4 310.2013 310.2005 -2.6 
 
 
Naproxen a C14H14O3 229.0870 229.0861 -3.9 
 
 
Norfluoxetine C16H16F3NO 296.1257 296.1250 -2.4 
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Paroxetine C19H20FNO3 330.1500 330.1491 -2.7 
 
 
Pentobarbital a C11H18N2O3 225.1245 225.1240 -2.2 
 
 
Phenobarbital a C12H12N2O3 231.0775 231.0771 -1.7 
 
 
Pindolol C14H20N2O2 249.1598 249.1593 -2.0 
 
 
Pravastatin C23H36O7 447.2353 447.2348 -1.1 
 
 
Propranolol C16H21NO2 260.1645 260.1639 -2.3 
 
 
Salbutamol C13H21NO3 240.1594 240.1591 -1.2 
 
 
Sertraline C17H17Cl2N 306.0811 306.0807 -1.3 
 
 
Sotalol C12H20N2O3S 273.1267 273.1261 -2.2 
 
 
Sulfamethoxazole C10H11N3O3S 254.0594 254.0589 -2.0 
 
 
Tamoxifen C26H29NO 372.2322 372.2315 -1.9 
 
 
Timolol C13H24N4O3S 317.1642 317.1640 -0.6 
 
  Trimethoprim C14H18N4O3 291.1452 291.1445 -2.4   
a Compounds detected in negative mode [M–H]– 
 
5.3.2 Tentative Identification of Phase II metabolites based on Accurate 
Mass 
Because this study focuses on phase II metabolites, the identification procedure 
will only be discussed for the cases when both parent drug and at least one of its 
metabolites are present together. On the basis of the fact that most phase II 
metabolites are more water soluble than the corresponding parent drugs (Ferrer 
and Thurman 2010), with the exception of acetylation (Gobel et al. 2004), an 
earlier retention time of a metabolite is a positive indication when tentatively 
identifying metabolites based on accurate mass. Moreover, it is difficult to be 
certain if the observed peak is a metabolite or another isomer without knowing 
the chromatographic behavior of the parent drug (Ferrer and Thurman 2012). 
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Peaks from full scan chromatograms that show intensities lower than 1 x 105 
counts will not be considered because the intensity would not be high enough to 
trigger a data-dependent MS/MS scan, which is essential for structure 
elucidation.  
Upon inputting the elemental composition and polarity of each selected 
pharmaceutical into MetWorks, XICs for the parent drug along with its most 
commonly found phase II metabolites are created based on the exact masses of 
modifications using a mass tolerance at 5 ppm.  These calculations were shown 
in Table 5.2.  
 
Table 5.2 Monitored phase II modifications and exact 
masses of the modifications to parent pharmaceuticals 
Phase II Modification 
Exact Mass of 
Modification 
Glucuronidation +176.0321 
Glutathione conjugation +307.0838 
Sulfation +79.9568 
Acetylation +42.0106 
Glycine conjugaion +57.0215 
Cysteine conjuation +103.0092 
Taurine conjugation +107.0041 
S-cysteine conjugation +119.0041 
N-acetylcysteine conjugation +161.0147 
Hydroxylation and Glucuronidation +192.0270 
Decarboxylation and Glucuronidation +148.0372 
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Hydroxylation and Sulfation +95.9517 
De-ethylation + Glucuronidation +148.0008 
De-methylation + Glucuronidation +162.0164 
Epoxidation + S-GSH conjugation +323.0787 
Desaturation + S-GSH conjugation +305.0682 
  
A detailed examination of the XICs for all potential metabolites in reclaimed water 
samples revealed that sulfamethoxazole glucuronide and acetyl-
sulfamethoxazole, two phase II metabolites of sulfamethoxazole, appeared at 
retention times of 5.38 min and 5.56 min, respectively (Figure 5.1). Meanwhile, a 
peak at 5.46 min was also observed for sulfamethoxazole as shown in Figure 
5.1. The retentive behaviors of these compounds were in good agreement with 
those reported in literature (Gobel et al. 2004), in which sulfamethoxazole eluted 
later than sulfamethoxazole glucuronide but earlier than acetyl-sulfamethoxazole. 
The accurate mass of sulfamethoxazole was observed at m/z 254.0590, which is 
-1.6 ppm from its exact mass at m/z 254.0594. For verification purposes, the 
mixture containing all parent pharmaceutical standards at 200 ng/mL was 
injected onto the column, and sulfamethoxazole standard was eluted at the same 
retention time with the same measured accurate mass (m/z 254.0590). 
Therefore, sulfamethoxazole can be identified in reclaimed water samples based 
on retention time and its elemental composition (less than 5 ppm). Additional 
confirmation was done by comparing MS/MS spectra with those obtained from 
sulfamethoxazole standard (Figure 5.2). 
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Figure 5.1 LC-Q Exactive Orbitrap extracted ion chromatograms (XICs) of 
sulfamethoxazole (m/z 254.0594), sulfamethoxazole glucuronide (m/z 430.0915) 
and acetyl-sulfamethoxazole (m/z 296.0700) in a reclaimed water sample; mass 
tolerance was set to 5 ppm for all compounds 
 
The accurate masses for both metabolites were measured at m/z 430.0916 and 
m/z 296.0695 (mass accuracy less than 1.7 ppm from their exact masses), 
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respectively, which correspond to the addition of glucuronic acid (176 Da) and 
acetyl group (42 Da) to sulfamethoxazole. These metabolites can only be 
tentatively identified at this point because standards and their detailed 
fragmentation patterns are needed to ensure their identities. Unfortunately, unlike 
metabolic studies where there are metabolite-free blank samples to compare 
with, and more importantly, there are much fewer compounds to deal with, 
environmental studies monitor dozens, sometimes hundreds of compounds 
which make purchasing or synthesizing metabolite standards for all compounds 
unrealistic and economically unsound. An alternative that could be applied here 
when metabolite standards are not readily available is to compare the similarities 
of fragmentation patterns between parent drug and its phase II metabolites as 
they share the “back bone” in their molecular structures (Lim et al. 2007; 
Thurman and Ferrer 2012). Moreover, combining high resolution accurate mass 
measurements and tandem mass spectrometry increases the confidence of the 
proposed structures of product ions. The availability of chemical formulas for all 
precursor and product ions, irrespective of relative ion abundance, generated 
from high resolution data-dependent spectra can also accelerate the structure 
elucidation of metabolites (Ferrer and Thurman 2010; Thurman and Ferrer 2012). 
Therefore, data-dependent spectra showing fragmentation patterns of 
sulfamethoxazole glucuronide and acetyl-sulfamethoxaozle were further 
investigated against that obtained for sulfamethoxazole using Mass Frontier.  
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5.3.3 Identification of Acetyl-sulfamethoxazole and Sulfamethoxazole 
Glucuronide 
The high resolution data-dependent MS/MS spectrum of m/z 254.0590 at 
retention time 5.46 min in the reclaimed water extract was shown In Figure 5.2B, 
which was nearly identical with that observed for sulfamethoxazole standard 
(Figure 5.2A). The two most abundant fragment ions at 156 Da and 108 Da were 
in good agreement with those reported in previous studies (Sacher et al. 2001; 
Vanderford et al. 2003). The structures of all major fragments were predicted by 
Mass Frontier on the basis of the fragmentation rules built into the software and 
labeled in Figure 5.2A and 5.2B. All the labeled fragment ions in Figure 5.2B 
matched within 1.8 ppm and satisfied the ion fragments predicted by Mass 
Frontier. The proposed fragmentation pathway is also shown in Figure 5.3A. 
Therefore, these high resolution MS/MS data clearly showed that the ion m/z 
254.0590 was sulfamethoxazole and once again confirmed the presence of 
sulfamethoxazole in the reclaimed water sample.  
Figure 5.2C shows the MS/MS spectrum of m/z 296.0695 at retention time 5.56 
min, which corresponds within -1.7 ppm to the exact mass of acetyl-
sulfamethoxazole. The four most intense fragment ions at 65 Da, 108 Da, 134 Da 
and 198 Da were consistent with those observed by Gobel et al (Gobel et al. 
2004) using unit resolution triple quadruple mass spectrometer. All labeled 
fragment ions in Figure 5.2C matched within 4.9 ppm and satisfied the ion 
fragments predicted by Mass Frontier. The proposed fragmentation pathway of 
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acetyl-sulfamethoxazole was also described in Figure 5.3B for the first time. 
Fragment ions at 134 Da, 150 Da, 198 Da and 236 Da containing acetyl groups 
clearly showed that these ions were generated from the acetylation of 
sulfamethoxazole suggesting that the m/z 296.0695 was indeed acetyl-
sulfamethoxazole. 
Similarly, Figure 5.2D shows the MS/MS spectrum of m/z 430.0916 at retention 
time 5.38 min, which corresponds within 0.2 ppm to the exact mass of 
sulmathoxoazole glucuronide. The m/z 430.0916 ion lost 176.0330 to form m/z 
254.0586, which is a loss within 4.5 ppm for the glucuronic acid. The ion m/z 
254.0586, which is -3.1 ppm from the exact mass of sulfamethoxazole, further 
fragmented to give two important ions at m/z 108.0445 (1.2 ppm mass accuracy) 
and m/z 156.0110 (-2.8 ppm mass accuracy), which were also observed as the 
two most abundant fragment ions for sulfamethxoazole standard (Figure 5.2A). 
These two ions together indicated that m/z 254.0586 was indeed 
sulfamethoxazole formed on the basis of the de-conjugation of glucuronic acid. 
The fragmentation pathway of the glucuronide conjugate was shown in Figure 
5.3C. Thus, the evidence is strong that the ion m/z 430.0916 is sulfamethoxazole 
glucuronide. 
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Figure 5.2 High resolution data-dependent MS/MS spectra and major fragments for A: sulfamethoxazole standard, B: 
sulfamethoxazole in reclaimed water, C: acetyl-sulfamethoxazole in reclaimed water, and D: sulfamethoxazole 
glucuronide in reclaimed water 
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Figure 5.3 Proposed fragmentation pathways for A: sulfamethoxazole, B: acetyl-
sulfamethoxazole, and C: sulfamethoxazole glucuronide 
5.3.4 Determination of Sulfamethoxazole and Its Metabolites in Reclaimed 
Water 
Collected reclaimed water samples were spiked with sulfamethoxazole-d4 (exact 
mass at m/z 258.0845) as surrogate internal standard and extracted as 
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described above. Quantitation was carried out in MS full scan mode at resolution 
70,000 only using the peak area from the extracted ion chromatograms of the 
base peak ion shown in table 5.1, using a mass tolerance of 5 ppm. Calibration 
curve for sulfamethoxazole was built at concentrations ranging from 0.1 ng/mL to 
200 ng/mL, with R2>0.99. Method detection limit for sulfamethoxazole in 
reclaimed water was determined at 67 ng/L (n=7). Recovery for 
sulfamethoxazole was 94 ± 14 % (n=3). Considering the structural similarity 
between sulfamethoxazole and its metabolites and the availability of metabolite 
standards, concentrations for acetyl-sulfamethoxazole and sulfamethoxazole 
glucuronide were tentatively determined based on the response factor obtained 
for sulfamethoxazole, regardless of potential matrix effects and ionization 
efficiency. I was able to achieve this approximation because these compounds 
were eluted fairly close to each other (within 0.22 min), thus may have suffered 
similar suppression or enhancement. Moreover, the aim of this study was to 
identify them and to determine the abundance of metabolites relative to their 
parent drugs in environmental water samples. Therefore, retention times and 
ions found in previous sections are now used for the determination of 
sulfamethoxazole and its metabolites in reclaimed water samples.  
5.3.5 Occurrence of Sulfamethoxazole and Its Metabolites in Reclaimed 
Water 
After the two phase II metabolites along with sulfamethoxazole have been 
successfully identified in one of the reclaimed water extracts of routine monitoring 
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for pharmaceuticals, the developed strategy was applied to screen phase II 
metabolites in the reclaimed water samples collected during a period of one 
month at Florida International University Biscayne Bay Campus (North Miami, 
FL). Sulfamethoxazole and its two metabolites are the only group of compounds 
that have been consistently detected in all the reclaimed water samples 
suggesting that the waste water treatment plant is fairly effective at removing 
most of the phase II metabolites. Sulfamethoxazole, on the other hand, may 
represent one of the few types of pharmaceuticals whose phase II metabolites 
can survive intact through sewage treatment plants. As shown in Figure 5.4, 
average concentrations of sulfamethoxazole, acetyl-sulfamethoxazole and 
sulfamethoxazole glucuronide were calculated at 2848 ± 1367 ng/L, 1980 ± 1410 
ng/L, and 2859 ± 1526 ng/L, respectively. The two metabolites represented 54 
%, on the basis of mole fraction, of the source of sulfamethoxazole in reclaimed 
water. With the knowledge that sulfamethoxazole and acetyl-sulfamethoxazole 
have been previously detected in wastewater, this is the first known report of 
sulfamethoxazole glucuronide occurring in environmental water samples. It is 
commonly believed that glucuronide conjugates are unstable during waste water 
treatment as a result of being used as an energy source for microbes, the 
presence of sulfamethoxazole glucuronide indicated that there might be certain 
factors, such as temperature and the complex consortium of bacteria present, 
that played a role in keeping the conjugates in reclaimed water. Although this is a 
small sample size and may not be representative for other treatment facilities, it 
is still important to be aware of that metabolites do pose a possible threat to 
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surface water and drinking water sources, and ultimately to confirm the 
importance of measuring pharmaceutical metabolites in the environment. 
Therefore, future studies will include more commonly prescribed pharmaceuticals 
and pay special attention to those undergo extensive phase II metabolism. 
5.4 Conclusions 
The combination of the high resolution Orbitrap mass spectrometry and 
metabolic profiling software was successfully applied for the analysis of 
pharmaceutical metabolites in reclaimed water. Sulfamethoxazole and its two 
phase II metabolites, acetyl-sulfamethoxazole and sulfamethoxazole glucuronide, 
were detected and successfully identified in reclaimed water samples using this 
technique. I also illustrated that it was helpful to use characteristic ions and 
MS/MS spectra to identify a compound when the standard is not available. 
Preliminary results showed that the method could be easily adapted to the 
analysis in various matrices such as sewage extracts, surface water and drinking 
water. The resulting data can be used to evaluate the performance of reclaimed 
water treatment procedures, also the fate of pharmaceuticals in wastewater 
treatment plants. In the case of sulfamethoxazole, the amount of acetyl-
sulfamethoxazole and sulfamethoxazole glucuronide needs to be considered in 
order to correctly assess the fate of sulfamethoxazole as they represent the 
major source of sulfamethoxazole in reclaimed water. 
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Figure 5.4 Occurrence of sulfamethoxazole and its two phase II metabolites 
acetyl-sulfamethoxazole and sulfamethoxazole glucuronide in reclaimed water 
during a period of one month (n=7) 
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CHAPTER 6 
Ecological risk assessment of pharmaceuticals in reclaimed water 
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6.1 Introduction 
As described previously, some pharmaceuticals are not completely eliminated 
because the conventional treatments used in WWTPs appear insufficient to 
completely remove these specific compounds (Daughton and Ternes 1999). 
Consequently, these pharmaceuticals can be released through reclaimed water 
in variable quantities and reach surface waters, ground waters, and sediments 
(Zuccato et al. 2000; Wang and Gardinali 2012). Although pharmaceuticals can 
be degraded in the environment by biotic and/or abiotic processes and their 
concentrations in environmental water bodies are typically at ng/L to low µg/L 
level, these organic pollutants may still pose risks to aquatic species under 
chronic long-term exposure (Sanderson et al. 2003; Gunnarsson et al. 2008; 
Pounds et al. 2008; Quinn et al. 2009; Berninger and Brooks 2010). Since many 
aquatic species were shown to have similar physiological receptors to those the 
pharmaceuticals are originally intended to react with in humans (Gunnarsson et 
al. 2008; Berninger and Brooks 2010), the probability of ecological risks that 
these compounds pose to aquatic organisms cannot be ruled out.  
Ecological risk assessment (ERA) is the process of analyzing and evaluating the 
probability of adverse ecological effects caused by environmental pollutants 
(USEPA 1998). In recently years, probabilistic approach which determines the 
probability of an exposure concentration exceeding the probability of effects has 
been increasingly used in ERA procedures (Solomon et al. 2001; Carriger and 
Rand 2008). This is because, when used correctly, it can introduce greater 
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statistical confidence into risk assessment when compared to traditional hazard 
quotient and assessment factor approaches (Wheeler et al. 2002). However, 
problems associated with assessing risk of pharmaceuticals include the very 
large number of pharmaceuticals in use today and the availability of good toxicity 
benchmarks. In addition, many pharmaceuticals are biologically degraded to 
active metabolites that have not been fully evaluated. Therefore, on the basis of 
previous results (Chapter 4), five bioaccumulative pharmaceuticals including 
caffeine, carbamazepine, diltiazem, diphenhydramine, and ibuprofen detected in 
the worst case multiple exposure of reclaimed water will be fully investigated 
regarding acute and chronic risks to aquatic organisms.  
The objective of this chapter is to assess the probabilistic risks associated with 
the pharmaceuticals in reclaimed water used for daily irrigation at Florida 
International University Biscayne Bay Campus. The procedures include risk 
analysis and risk characterization by comparing distributions of exposure 
concentrations of these pharmaceuticals with species sensitivity distribution data 
from well described laboratory toxicity studies.  
6.2 Methods 
6.2.1 Exposure and toxicity data 
Concentrations of the five bioaccumulative pharmaceuticals in reclaimed water 
were obtained from Chapter 4 (Table 4.2), and charted in Figure 6.1. Measured 
concentrations were ranked from the smallest to the highest to assign a centile 
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ranking (j) using equation j × 100 / (n+1), where j is the rank and n is the total 
number of observations (Hall et al. 2009).  
Acute (LC50/EC50) and chronic (NOEC) laboratory toxicity data for water 
exposure were collected from USEPA AQUIRE database and literatures (Pina-
Vaz et al. 2000; Kim et al. 2007; Moore et al. 2008; Pounds et al. 2008; Kim et al. 
2009; Quinn et al. 2009; Berninger et al. 2011; Li et al. 2011), and used to 
develop species sensitivity distributions (SSDs) for each pharmaceutical. For a 
distribution to be considered for analysis, at least four suitable species end points 
were used to construct SSDs (Wheeler et al. 2002; Carriger and Rand 2008). 
Only toxicity data characterized by a specified end point that could be clearly 
related to changes in population structure such as growth, reproduction and 
survival were used in the SSDs. Where data from multiple studies on the same 
species were available, the geometric mean toxicity values were used to 
represent the species in the distribution (Carriger and Rand 2008). End point 
values greater than water solubility were excluded. Chronic toxicity data for 
diltiazem were limited and the SSD could not be developed. 
All toxicity data used for SSDs were assumed to fit a log-logistic distribution and 
graphical output was produced by an EPA SSD generator 
(http://www.epa.gov/caddis/downloads/SSD_Generator_V1.xlt). Log-transformed 
end point concentrations were plotted against the cumulative probabilities for 
each species. The 10th centile for each SSD was determined and chosen as the 
primary benchmark or threshold for effects on communities of aquatic species 
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(Wheeler et al. 2002), however, the 5th centile values were also calculated for 
comparison purposes. 
6.2.2 Risk assessment 
Risk was assessed by comparing the overlap of the distributions of exposure 
concentrations and the SSDs. The estimated 90th centile of exposure 
concentrations were compared to the estimated 10th and 5th centile 
concentrations from the acute SSDs (Solomon et al. 2001). The 90th centile 
represents a concentration that would only be expected to occur 10% of the time 
and would represent episodic or pulsed exposures (Rand et al. 2010). The 
estimated 50th centile exposure concentrations were compared to the estimated 
10th and 5th centile concentrations of the chronic SSDs (Solomon et al. 2001). 
The 50th centile concentration was chosen as a comparison to chronic SSDs on 
the basis of that it might be more representative of background concentrations as 
50% of the exposures are anticipated to be above or below this level at a site 
(Rand et al. 2010).  
When a centile from exposure distribution data was applied to SSD, the 
potentially affected fraction (PAF) of species was calculated (Van Beelen et al. 
2001; van de Meent and Huijbregts 2005). Any exceedences above the 10th 
centile of a SSD were noted for acute and chronic risk. The PAF is important to 
understand the fraction of species that is expected to be potentially affected 
above its acute or chronic benchmark at a given environmental concentration. 
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The calculation for PAF is shown in the following equation (Carriger and Rand 
2008).  
where α is the mean of log toxicity data, β is equal to σ × 3 /π while σ is the 
standard deviation and x is the log of the exposure concentration. As described 
above, x was determined to be the 90th and 50th centiles of the exposure 
distribution for acute and chronic effects, respectively.  
Next, joint probability curves (JPCs) were constructed for the pharmaceuticals 
that showed the highest PAF values. Joint probability curve is a function of 
probability of exposure and magnitude of ecological effects and used to 
determine the proportion of toxicity values from the SSD that are exceeded by 
ranges of exposure concentrations (Carriger and Rand 2008). For instance, a 
JPC for pharmaceutical A shows that there is a 5% probability that the exposure 
of A will affect 10% of the species in SSD, but another JPC for pharmaceutical B 
may present 15% probability that the exposure of B will affect the same 
proportion of species in SSD. One can conclude that pharmaceutical B may pose 
higher risk than pharmaceutical A to aquatic species and is therefore of greater 
concern.  Therefore, JPC provides a means of comparing relative potential risk 
when toxicity and exposure data are sufficiently robust. 
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6.3 Results and discussions 
Exposure concentrations of the selected pharmaceuticals in reclaimed water are 
shown in Figure 6.1 as boxplot. The bar closest to zero indicates the 10th centile, 
a line within the box marks the median (50th centile), and the bar farthest from 
zero indicates the 90th centile. The 50th and 90th centiles of the exposure 
concentrations were determined and presented in Table 6.1. The highest 90th 
and 50th centile concentrations occurred for caffeine at 9.66 µg/L and 8.39 µg/L, 
respectively. The lowest 90th and 50th centile concentrations occurred for 
diltiazem at 0.183 µg/L and 0.159 µg/L, respectively. 
 
Figure 6.1 Boxplot of exposure concentrations (n=7) of selected pharmaceuticals 
in reclaimed water 
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The acute and chronic SSDs for the selected pharmaceuticals are shown in 
Figure 6.2 and Figure 6.3, respectively. A summary of the acute and chronic 
toxicity data including the 5th and 10th centiles from respective SSDs is 
presented in Table 6.2. Chronic SSD for diltiazem was not constructed as a 
result of limited chronic toxicity data. All centile concentrations from both acute 
and chronic toxicity data were at least one order of magnitude higher than the 
exposure concentrations, except for the chronic 5th and 10th centile 
concentrations of carbamazepine. The results indicate that carbamazepine may 
pose higher risk than other pharmaceuticals as it is the only compound that 
shows overlap between the exposure concentrations and the toxicity data. 
However, further probabilistic assessment is needed to confirm the risk and the 
results will be discussed later.  
 
 
 
 
 
 
Table 6.1 90th and 50th centiles of exposure 
concentrations 
 90th centile of exposure 
concentration (µg/L) 
50th centile of 
exposure 
concentration (µg/L)  
caffeine 9.66 8.39 
carbamazepine 1.37 1.18 
diltiazem 0.183 0.159 
diphenhydramine 6.72 5.53 
ibuprofen 0.359 0.347 
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All the chronic toxicity data were lower than the acute toxicity data indicating that 
the aquatic organisms under chronic exposure of these pharmaceuticals are 
more likely to be affected than under the acute exposures. The chronic and acute 
SSD centile concentrations were relatively close (within one order of magnitude) 
for caffeine and diphenhydramine. Carbamazepine and ibuprofen, on the other 
hand, had much lower chronic toxicity centile concentrations than their acute 
values (Table 6.2), suggesting that chronic exposure of carbamazepine or 
ibuprofen may pose higher risks than acute exposure.  
Table 6.2 The 5th and 10th centiles of toxicity data from acute and 
chronic SSDs 
 Acute SSD Chronic SSD 
 
5th 
centile 
(µg/L) 
10th centile 
(µg/L) 
5th 
centile 
(µg/L) 
10th centile 
(µg/L) 
caffeine 16039 26070 4465 7442 
carbamazepine 2253 3730 3.90 14.2 
diltiazem 2479 4041 N/A N/A 
diphenhydramine 438 598 139 336 
ibuprofen 3977 5992 64 160 
N/A indicates that data were not available for the compound. 
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Figure 6.2 Acute species sensitivity distributions with 95% Confidence Interval for 
caffeine, carbamazepine, diltiazem, diphenhydramine and ibuprofen 
 
 120 
 121 
 
Figure 6.3 Chronic species sensitivity distributions with 95% Confidence Interval 
for caffeine, carbamazepine, diphenhydramine and ibuprofen 
 
Potentially affected fractions were calculated and shown in Table 6.3. The 
potentially affected fraction values for caffeine, diltiazem and ibuprofen were 
zero. The results indicate that there was no overlap between the exposure 
concentration and the SSD for each pharmaceutical. Acute and chronic PAFs for 
diphenhydramine were calculated at 0.1% and 0.3%, respectively. Chronic PAF 
for carbamazepine was calculated at 2.4%, but the values (less than 3%) were 
generally considered low (Carriger and Rand 2008; Xing 2012). 
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Table 6.3 Statistics and potentially affected fraction (PAF) for acute and 
chronic toxicity data for pharmaceuticals 
  x α σ β PAF % 
caffeine 
Acute 0.985 4.339 0.616 0.340 0.0 
Chronic 0.924 4.654 0.535 0.295 0.0 
carbamazepine 
Acute 0.137 4.307 0.522 0.288 0.0 
Chronic 0.071 3.128 1.493 0.823 2.4 
diltiazem 
Acute -0.737 4.355 0.564 0.311 0.0 
Chronic -0.799 N/A N/A N/A N/A 
diphenhydramine 
Acute 0.828 3.041 0.557 0.307 0.1 
Chronic 0.743 3.876 0.990 0.546 0.3 
ibuprofen 
Acute -0.445 4.406 0.474 0.262 0.0 
Chronic -0.460 3.468 0.847 0.467 0.0 
N/A indicates that data were not available for the compound. 
Zero indicates that there was no overlap between the exposure concentration 
and the SSD. 
 
On the basis of chronic PAF values, carbamazepine could be considered as a 
compound of concern. Therefore, a JPC was developed and shown in Figure 6.4. 
It can be seen that the curve was extremely close to the axes. As a matter of 
fact, the probability for 5% of species affected was zero, indicating a very small 
probability of adverse effects.  
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Figure 6.4 Joint probability curve for the exposure concentration and chronic 
toxicity data of carbamazepine 
6.4 Conclusion 
In this chapter, five bioaccumulative pharmaceuticals including caffeine, 
carbamazepine, diltiazem, diphenhydramine and ibuprofen detected in reclaimed 
water were investigated to assess the potential acute and chronic risks to aquatic 
organisms. The results showed that aquatic organisms under chronic exposure 
of these pharmaceuticals are more likely to be affected than under acute 
exposure. In addition, the joint probability curve for the exposure and chronic 
toxicity data of carbamazepine indicated a quantifiably low potential risk even 
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under the worst case exposure to reclaimed water. Given the dilution factors that 
affect environmental releases, the risk of exposure to carbamazepine will be 
even more decreased.   
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CONCLUSIONS 
The overall objectives of this research were to develop analytical methods for the 
determination of trace level pharmaceuticals and metabolites as emerging 
environmental contaminants using the-state-of-art mass spectrometry in different 
matrices, and to gain knowledge about the occurrence, distribution and variance 
of these pharmaceutically active compounds in the South Florida environment as 
well as the information regarding bioconcentration factors and pharmacokinetics 
in aquatic species being affected by wastewater under various exposure 
scenarios.  
As a result, two protocols were successfully developed for targeted analysis and 
unknown phase II metabolites screening. A specific and sensitive triple quadruple 
mass spectrometer was used in the targeted analysis of pharmaceuticals in 
mosquito fish and surface water directly affected by reclaimed water. A high 
resolution Orbitrap mass spectrometer was used in the phase II metabolites 
screening.  
After a comprehensive evaluation of a large number of environmental samples, it 
was confirmed that a number of pharmaceuticals at concentrations that could 
range up to μg/L were routinely introduced into the environment from a typical 
secondary wastewater treatment plant. Compounds such as caffeine, 
diphenhydramine and carbamazepine were consistently detected in reclaimed 
water and surface water from a fresh water pond directly affected by reclaimed 
water. Bioaccumulation factors for caffeine, diphenhydramine and 
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carbamazepine in mosquito fish living in this pond were also calculated and 
found at 29 ± 26, 821 ± 422 and 108 ± 144, respectively. 
In order to understand the uptake and depuration as well as bioconcentration 
factors (BCFs) under the worst-case conditions, mosquito fish were exposed to 
reclaimed water under static-renewal for 7 days, followed by a 14-day depuration 
phase in clean water. The results showed that some pharmaceuticals such as 
diphenhydramine could be accumulated in fish up to 82 ng/g while some 
pharmaceuticals such as caffeine will rather equilibrate with the surrounding 
waters and would persist for a period of several days. The study also showed 
that a number of other compounds detected in rather high concentrations (e.g. 
diclofenac and gemfibrozil) did not accumulate in fish despite having moderately 
high Log Kow values implying that other mechanisms may have played a role in 
keeping them in solution. Because many aquatic species have similar 
physiological receptors to those originally targeted for pharmacological effects in 
humans, non-target species under chronic exposure may show potential adverse 
effects.  
Next, the combination of the power of high resolution Orbitrap mass spectrometry 
and metabolic profiling software was successfully applied for the analysis of 
pharmaceutical metabolites in reclaimed water. Sulfamethoxazole and its two 
phase II metabolites, acetyl-sulfamethoxazole and sulfamethoxazole glucuronide, 
were successfully identified in reclaimed water using this technique. It was also 
illustrated that it was helpful to use characteristic ions and MS/MS spectra to 
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identify a compound when the standard is not available. Preliminary results 
showed that the method could be easily adapted to the analysis in various 
matrices such as sewage extracts, surface water and drinking water. The 
resulting data can be used to evaluate the performance of reclaimed water 
treatment procedures, also the fate of pharmaceuticals in wastewater treatment 
plants. In the case of sulfamethoxazole, the amount of acetyl-sulfamethoxazole 
and sulfamethoxazole glucuronide needs to be considered in order to correctly 
assess the fate of sulfamethoxazole as they represent the major source of 
sulfamethoxazole in the reclaimed water. 
Finally, five bioaccumulative pharmaceuticals including caffeine, carbamazepine, 
diltiazem, diphenhydramine and ibuprofen detected in reclaimed water were 
investigated regarding the acute and chronic risks to aquatic organisms. The 
results showed that aquatic organisms under chronic exposure of carbamazepine 
are more likely to be affected than the exposures of any other selected 
pharmaceuticals. In addition, the joint probability curve for the exposure and 
chronic toxicity data of carbamazepine indicated a low potential risk of 
carbamazepine even under the worst case exposure scenario. However, given 
the dilution factors that affect environmental releases, the risk of exposure to 
carbamazepine will be drastically decreased. 
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